Rapamycin (Sirolimus) has been evaluated across numerous clinical trials spanning Early Phase 1 through Phase 4, sponsored by academic medical centers, university hospitals such as Karolinska Institutet and Huashan Hospital, and biotechnology companies like Aadi Bioscience Inc. Key indications under evaluation include neuroendocrine tumors, Familial Adenomatous Polyposis, Alzheimer disease, Celiac Disease, brainstem cavernous malformations, and immunosuppression following renal transplantation. These protocols encompass various recruitment statuses, ranging from actively recruiting and enrolling by invitation to completed and terminated studies.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06876142 | SUSPENDED | Multiple Myeloma; Relapsed and/or Refractory Multiple Myeloma (RRMM) |
National Cancer Institute (NCI) |
2026-09-09 | PHASE1; PHASE2 |
| NCT05463133 | RECRUITING | Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-07-08 | PHASE1; PHASE2 |
| NCT06325709 | RECRUITING | Chronic Granulomatous Disease (CGD); X-Linked Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2024-04-17 | PHASE1; PHASE2 |
| NCT07725380 | RECRUITING | Sarcoma; Osteosarcoma |
H. Lee Moffitt Cancer Center and Research Institute |
2026-07-15 | PHASE1; PHASE2 |
| NCT07735533 | NOT_YET_RECRUITING | Lymphoma, B Cell; Lymphoma Non-Hodgkin; High Grade B Cell Lymphoma; Richter Transformation Lymphoma; Grade 3b Follicular Lymphoma; Primary Mediastinal B Cell Lymphoma; Diffuse Large B Cell Lymphoma (DLBCL) |
Umoja Biopharma |
2026-08 | PHASE1; PHASE2 |
| NCT07715734 | NOT_YET_RECRUITING | Kidney Transplant Recipient; Cutaneous Squamous Cell Carcinoma (CSCC); Advanced Cutaneous Squamous Cell Carcinoma; Kidney Transplant |
Washington University School of Medicine |
2026-09-30 | PHASE2 |
| NCT07022587 | RECRUITING | De Novo Stenosis; Coronary Artery Disease |
Xijing Hospital |
2025-12-20 | |
| NCT07162038 | RECRUITING | Hematologic Malignancies; Hematologic Neoplasms |
National Cancer Institute (NCI) |
2025-11-14 | PHASE1 |
| NCT03587272 | RECRUITING | Sickle Cell Disease |
Robert Nickel |
2018-04-17 | PHASE2 |
| NCT06308445 | NOT_YET_RECRUITING | Familial Adenomatous Polyposis |
University Hospital, Toulouse |
2026-09-01 | PHASE2 |
| NCT06950385 | RECRUITING | Familial Adenomatous Polyposis (FAP) |
Rapamycin Holdings Inc. |
2025-07-18 | PHASE3 |
| NCT07735546 | NOT_YET_RECRUITING | Multiple Myeloma in Relapse; Multiple Myeloma (MM) |
Umoja Biopharma |
2026-10-01 | PHASE1 |
| NCT05549167 | RECRUITING | Juvenile Nasopharyngeal Angiofibroma |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2022-05-30 | PHASE3 |
| NCT07104331 | RECRUITING | Epithelioid Hemangioendothelioma (EHE) |
Sarcoma Alliance for Research through Collaboration |
2026-02-24 | PHASE2 |
| NCT07581704 | RECRUITING | Multiple Myeloma |
Christopher Strouse |
2026-06-01 | PHASE1 |
| NCT05233722 | RECRUITING | Insulin Sensitivity |
University of Copenhagen |
2022-02-10 | |
| NCT03121001 | RECRUITING | Sickle Cell Disease |
University of Illinois at Chicago |
2017-03-20 | PHASE2 |
| NCT07081763 | NOT_YET_RECRUITING | HIV-1-infection |
ANRS, Emerging Infectious Diseases |
2026-05 | PHASE2 |
| NCT07582172 | RECRUITING | Acute Myeloid Leukemia With Complex Karyotype; Myelodysplastic Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Recurrent Secondary Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome; Refractory Secondary Acute Myeloid Leukemia |
City of Hope Medical Center |
2027-04-05 | PHASE2 |
| NCT06708455 | NOT_YET_RECRUITING | Malignant Melanoma With Metastasis; Malignant Melanoma; Malignant Melanoma Stage IIIc; Malignant Melanoma Stage IV |
Rapa Therapeutics LLC |
2027-03-01 | PHASE2 |
| NCT06528301 | RECRUITING | Lymphoma, B-Cell; Lymphoma, Non-Hodgkin (NHL); Lymphoma, Large B-Cell, Diffuse (DLBCL); Chronic Lymphocytic Leukemia (CLL) |
Umoja Biopharma |
2025-03-10 | PHASE1 |
| NCT04469530 | RECRUITING | Solid Tumor |
Emory University |
2020-09-16 | PHASE2 |
| NCT04199026 | RECRUITING | Metastatic Sarcoma; Recurrent Sarcoma; Resectable Sarcoma |
M.D. Anderson Cancer Center |
2025-02-25 | |
| NCT01499888 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
University of Illinois at Chicago |
2011-11-11 | PHASE1; PHASE2 |
| NCT07165886 | RECRUITING | Gastroenteropancreatic Neuroendocrine Tumors |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2025-08-29 | PHASE2; PHASE3 |
| NCT06658093 | RECRUITING | Aging |
The University of Texas Health Science Center at San Antonio |
2026-03-04 | EARLY_PHASE1 |
| NCT06743503 | RECRUITING | Large B-cell Lymphoma |
Nanjing IASO Biotechnology Co., Ltd. |
2025-04-11 | PHASE1 |
| NCT06287944 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
City of Hope Medical Center |
2025-07-01 | PHASE1 |
| NCT05650411 | RECRUITING | Left Main Coronary Artery Stenosis |
IGLESIAS Juan Fernando |
2026-04-26 | |
| NCT05088356 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Cell Transplantation (HCT); Advanced Hematologic Malignancies; Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders |
Stanford University |
2021-09-07 | PHASE1 |
| NCT06437574 | RECRUITING | Prostate Cancer |
Cedars-Sinai Medical Center |
2024-07-16 | PHASE2 |
| NCT06973668 | RECRUITING | AML |
M.D. Anderson Cancer Center |
2025-07-22 | PHASE2 |
| NCT07570433 | NOT_YET_RECRUITING | CMV Infection |
Oriol Manuel |
2026-04 | PHASE4 |
| NCT07728175 | NOT_YET_RECRUITING | Genetic Predisposition to Disease; Healthy Volunteer; APOE-4 Positive |
University of Missouri-Columbia |
2026-12-01 | PHASE1 |
| NCT07662174 | NOT_YET_RECRUITING | Post-hemorrhagic Hydrocephalus (PHH) |
Massachusetts General Hospital |
2027-01-01 | PHASE1; PHASE2 |
| NCT02629120 | ACTIVE_NOT_RECRUITING | Chronic Granulomatous Disease Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-12-17 | PHASE1; PHASE2 |
| NCT05342519 | ACTIVE_NOT_RECRUITING | Vitiligo |
Medical University of South Carolina |
2022-07-28 | PHASE2 |
| NCT04861064 | RECRUITING | Venous Malformation; Lymphatic Malformation |
Medical University of South Carolina |
2022-01-18 | PHASE2 |
| NCT06843811 | ENROLLING_BY_INVITATION | Leigh Syndrome |
Matthew Demczko |
2025-02-27 | PHASE2 |
| NCT07052929 | RECRUITING | X-Linked Myotubular Myopathy |
Astellas Gene Therapies |
2025-12-15 | PHASE1; PHASE2 |
| NCT07241936 | RECRUITING | Advanced Solid Tumors |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2025-11-13 | PHASE1; PHASE2 |
| NCT06959771 | RECRUITING | CD40L-HyperIgM Syndrome |
National Institute of Allergy and Infectious Diseases (NIAID) |
2025-07-16 | PHASE1; PHASE2 |
| NCT05805605 | RECRUITING | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Biphenotypic Acute Leukemia; Undifferentiated Leukemia; Prolymphocytic Leukemia; Chronic Myelogenous Leukemia; Plasma Cell Leukemia; Myelodysplastic Syndromes; Leukemia, Myeloid; Myelodysplastic Syndrome With Excess Blasts-1; Burkitt Lymphoma; Relapsed T-Cell Lymphoma; Relapsed Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Marginal Zone Lymphoma; Follicular Lymphoma; Myeloproliferative Neoplasm; Myelofibrosis |
Masonic Cancer Center, University of Minnesota |
2023-05-01 | PHASE2 |
| NCT06925971 | NOT_YET_RECRUITING | Intracranial Arteriosclerosis |
MicroPort NeuroTech Co., Ltd. |
2025-04-15 | PHASE3 |
| NCT06941142 | NOT_YET_RECRUITING | Advanced Breast Cancer |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2025-04-30 | PHASE1 |
| NCT07436611 | NOT_YET_RECRUITING | Port Wine Stains |
AFT Pharmaceuticals, Ltd. |
2026-08 | PHASE2 |
| NCT06928883 | NOT_YET_RECRUITING | Coronary Arterial Disease (CAD); Vulnerable Coronary Plaques; Multivessel Coronary Artery Disease; Coronary Vessel; Acute Coronary Syndromes (ACS) |
Cardiocentro Ticino |
2025-04 | |
| NCT05860881 | ACTIVE_NOT_RECRUITING | Solid Organ Transplant Recipients; Skin Cancer |
Melanoma and Skin Cancer Trials Limited |
2024-02-09 | PHASE3 |
| NCT07796620 | NOT_YET_RECRUITING | Acute Leukemia; Myelodysplastic Syndromes; Severe Aplastic Anemia (SAA) |
Peking University People's Hospital |
2026-10-01 | PHASE1; PHASE2 |
| NCT07131644 | NOT_YET_RECRUITING | Kaposiform Hemangioendothelioma |
West China Hospital |
2025-09-13 | PHASE2 |
| NCT02042326 | RECRUITING | Arteriovenous Malformations |
Centre Hospitalier Universitaire, Amiens |
2014-09-12 | PHASE2 |
| NCT07542314 | NOT_YET_RECRUITING | Duchenne Muscular Dystrophy |
Sarepta Therapeutics, Inc. |
2026-08-31 | PHASE4 |
| NCT04888741 | RECRUITING | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Myelogenous Leukemia; Myelofibrosis |
University of Birmingham |
2021-02-22 | PHASE2 |
| NCT07566091 | NOT_YET_RECRUITING | Coronary Artery Disease |
Jung-min Ahn |
2026-06-15 | |
| NCT07058974 | ACTIVE_NOT_RECRUITING | Smokers; Former Smokers |
Icahn School of Medicine at Mount Sinai |
2025-08-12 | PHASE1 |
| NCT05534672 | RECRUITING | Tuberous Sclerosis Complex |
Katarzyna Kotulska |
2023-01-23 | PHASE3 |
| NCT07634120 | NOT_YET_RECRUITING | Vertebrobasilar Dolichoectasia |
Huashan Hospital |
2026-06 | PHASE2 |
| NCT05414292 | RECRUITING | Muscle Atrophy; Age-Related Sarcopenia |
University of Nottingham |
2021-08-06 | |
| NCT07191353 | RECRUITING | Healthy; Osteopenia; Osteoporosis Risk |
Odense University Hospital |
2025-10-20 | PHASE2 |
| NCT03243019 | RECRUITING | Lymphatic Malformation; Pediatric |
University Hospital, Lille |
2018-06-25 | PHASE2 |
| NCT04411654 | ACTIVE_NOT_RECRUITING | Gaucher Disease, Type 2 |
Prevail Therapeutics |
2021-06-29 | PHASE1; PHASE2 |
| NCT04375813 | ACTIVE_NOT_RECRUITING | Non-muscle Invasive Bladder Cancer |
Robert Svatek |
2021-01-25 | PHASE2 |
| NCT06084780 | NOT_YET_RECRUITING | Secondary Malignant Neoplasm of Retroperitoneum; Secondary Malignant Neoplasm of Peritoneum; Pseudomyxoma Peritonei |
Case Comprehensive Cancer Center |
2026-08 | PHASE2 |
| NCT03297606 | RECRUITING | Lymphoma, Non-Hodgkin; Multiple Myeloma; Advanced Solid Tumors |
Canadian Cancer Trials Group |
2018-03-23 | PHASE2 |
| NCT05746689 | NOT_YET_RECRUITING | IgG4-related Disease |
Peking University International Hospital |
2023-03-01 | |
| NCT06673290 | RECRUITING | Lymphatic Malformation |
West China Hospital |
2024-11-30 | PHASE2; PHASE3 |
| NCT06504420 | NOT_YET_RECRUITING | Primary Antiphospholipid Syndrome |
Peking University People's Hospital |
2024-10-15 | PHASE2 |
| NCT05997017 | RECRUITING | Endometrial Cancer; Endometrioid Tumor; Cancer; Tumor; Recurrent Endometrial Carcinoma; Endometrioid Endometrial Cancer |
Aadi Bioscience, Inc. |
2023-12-28 | PHASE2 |
| NCT04893291 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease; Coronary Artery Stenosis |
Fondazione Ricerca e Innovazione Cardiovascolare ETS |
2021-11-16 | |
| NCT01087554 | ACTIVE_NOT_RECRUITING | Advanced Cancer |
M.D. Anderson Cancer Center |
2010-03 | PHASE1 |
| NCT07159087 | ENROLLING_BY_INVITATION | Coronary Arterial Disease (CAD) |
Genoss Co., Ltd. |
2025-02-19 | |
| NCT03203525 | TERMINATED | Advanced Malignant Neoplasm; Colorectal Carcinoma Metastatic in the Liver; Metastatic Malignant Neoplasm in the Liver; Refractory Malignant Neoplasm |
M.D. Anderson Cancer Center |
2020-06-23 | PHASE1 |
| NCT06214819 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease |
Fundación EPIC |
2024-03-20 | |
| NCT07587801 | NOT_YET_RECRUITING | Vaccine Immune Response; Haemodialysis Patients; Older Adults |
Central Adelaide Local Health Network Incorporated |
2026-05 | PHASE2 |
| NCT05104983 | RECRUITING | Tuberous Sclerosis Complex; Epilepsy |
Darcy Krueger |
2021-10-13 | PHASE2 |
| NCT05661461 | RECRUITING | Tumor, Solid; Tumor; Advanced Solid Tumor |
Aadi Bioscience, Inc. |
2022-11-23 | PHASE1 |
| NCT06822712 | RECRUITING | Coronary Arterial Disease (CAD) |
BrosMed Medical Co., Ltd |
2025-03-03 | |
| NCT01552434 | TERMINATED | Advanced Malignant Neoplasm; Castleman Disease; Digestive System Carcinoma; Erdheim-Chester Disease; Lip and Oral Cavity Carcinoma; Lymphangioleiomyomatosis; Malignant Endocrine Neoplasm; Malignant Female Reproductive System Neoplasm; Malignant Male Reproductive System Neoplasm; Malignant Neoplasm; Malignant Respiratory Tract Neoplasm; Malignant Thoracic Neoplasm; Malignant Urinary System Neoplasm; Mesothelial Neoplasm; Metastatic Malignant Neoplasm; Metastatic Urothelial Carcinoma; Neurofibromatosis Type 2; Recurrent Adult Soft Tissue Sarcoma; Recurrent Breast Carcinoma; Recurrent Childhood Soft Tissue Sarcoma; Recurrent Digestive System Carcinoma; Recurrent Female Reproductive System Carcinoma; Recurrent Male Reproductive System Carcinoma; Recurrent Malignant Neoplasm; Recurrent Pharyngeal Carcinoma; Recurrent Thyroid Gland Carcinoma; Refractory Malignant Neoplasm; Soft Tissue Neoplasm; Stage III Breast Cancer AJCC v7; Stage III Pharyngeal Cancer; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7; Stage IV Pharyngeal Cancer; Stage IVA Pharyngeal Cancer; Stage IVB Pharyngeal Cancer; Stage IVC Pharyngeal Cancer; Thyroid Gland Neoplasm |
M.D. Anderson Cancer Center |
2012-10-16 | PHASE1 |
| NCT05406622 | ACTIVE_NOT_RECRUITING | Critical Limb Ischemia |
REVA Medical, Inc. |
2022-06-10 | |
| NCT04772300 | ACTIVE_NOT_RECRUITING | Peripheral Artery Disease |
Jena University Hospital |
2022-02-10 | |
| NCT07475546 | ACTIVE_NOT_RECRUITING | Healthspan Improvement; Aging; Longevity |
AgelessRx |
2025-07-23 | PHASE3 |
| NCT03292861 | ENROLLING_BY_INVITATION | Heart Transplantation |
Cedars-Sinai Medical Center |
2018-09-13 | PHASE2 |
| NCT04629495 | ACTIVE_NOT_RECRUITING | Mild Cognitive Impairment; Alzheimer Disease |
The University of Texas Health Science Center at San Antonio |
2021-08-11 | PHASE2 |
| NCT07354620 | ACTIVE_NOT_RECRUITING | Aging |
The Christ Hospital |
2025-02-15 | EARLY_PHASE1 |
| NCT06239480 | ACTIVE_NOT_RECRUITING | Microcystic Lymphatic Malformation |
Palvella Therapeutics, Inc. |
2024-07-31 | PHASE3 |
| NCT05144698 | RECRUITING | Solid Tumor; Small Cell and Non-small Cell Lung Cancer; Head and Neck Cancer; Squamous Cell Carcinoma of Oral Cavity; Squamous Cell Carcinoma of Larynx; Squamous Cell Carcinoma of Nasopharynx; Squamous Cell Carcinoma of Other Specified Sites of Skin; Malignant Melanoma; Esophageal Squamous Cell Carcinoma |
Rapa Therapeutics LLC |
2021-08-01 | PHASE1; PHASE2 |
| NCT04995159 | NOT_YET_RECRUITING | Coronary Heart Disease |
Lepu Medical Technology (Beijing) Co., Ltd. |
2021-09 | |
| NCT06802055 | RECRUITING | Aplastic Anaemia |
Peking Union Medical College Hospital |
2025-01-25 | PHASE2 |
| NCT05971394 | UNKNOWN | Infrapopliteal Lesions; Critical Limb Ischemia |
Biotyx Medical (Shenzhen) Co., Ltd. |
2023-07-17 | |
| NCT04238546 | ACTIVE_NOT_RECRUITING | Peripheral Arterial Disease |
Nils Kucher |
2020-11-03 | |
| NCT04177004 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Stem Cell Transplant Recipient; Hematopoietic and Lymphoid Cell Neoplasm |
City of Hope Medical Center |
2021-04-30 | PHASE1 |
| NCT04511234 | RECRUITING | Peripheral Artery Disease; Atherosclerosis; Arterial Disease |
Concept Medical Inc. |
2020-09-08 | |
| NCT06653842 | ACTIVE_NOT_RECRUITING | Cutaneous Venous Malformations |
Palvella Therapeutics, Inc. |
2024-12-20 | PHASE2 |
| NCT06145282 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2023-12-28 | PHASE1; PHASE2 |
| NCT05836025 | ACTIVE_NOT_RECRUITING | Perimenopausal |
Columbia University |
2023-06-01 | PHASE2 |
| NCT06856200 | RECRUITING | Advanced HR - Positive, HER2 - Negative Breast Cancer; Resistant to (Neo)Adjuvant Endocrine Therapy |
Fudan University |
2025-02-28 | |
| NCT05386914 | ACTIVE_NOT_RECRUITING | Genetic Predisposition to Disease; Healthy Volunteers |
University of Missouri-Columbia |
2023-03-02 | PHASE1 |
| NCT06029569 | UNKNOWN | Peripheral Arterial Disease |
Shanghai Bomaian Medical Technology Co., Ltd |
2023-09-15 | |
| NCT04742777 | COMPLETED | Aging |
The University of Texas Health Science Center at San Antonio |
2022-02-01 | PHASE2 |
| NCT07092618 | RECRUITING | Longevity; GLP-1; Geroscience; Aging |
AgelessRx |
2024-12-17 | PHASE2; PHASE3 |
| NCT06683118 | UNKNOWN | Cerebral Atherosclerotic Stenosis |
MicroPort NeuroTech Co., Ltd. |
2024-05-27 | |
| NCT06940895 | COMPLETED | Acanthosis Nigricans |
Narrows Institute for Biomedical Research |
2025-03-01 | PHASE2 |
| NCT05662618 | UNKNOWN | Peripheral Arterial Disease |
Shanghai Bomaian Medical Technology Co., Ltd |
2022-12-31 | |
| NCT04660240 | UNKNOWN | Diabetes Mellitus; Coronary Artery Disease; Acute Coronary Syndrome |
Instituto Nacional de Cardiologia Ignacio Chavez |
2020-10-01 | |
| NCT05719883 | COMPLETED | Intracranial Arteriosclerosis; Stroke (CVA) or TIA |
Beijing Tiantan Hospital |
2023-02-20 | |
| NCT04582136 | ACTIVE_NOT_RECRUITING | Systemic Lupus Erythematosus |
Chinese SLE Treatment And Research Group |
2021-03-04 | PHASE3 |
| NCT02638389 | RECRUITING | Vascular Malformations |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2016-01-25 | PHASE3 |
| NCT03008148 | UNKNOWN | Glioblastoma |
Johnpro Biotech, Inc. |
2018-10-11 | PHASE2; PHASE3 |
| NCT03304678 | COMPLETED | Lymphangioleiomyomatosis |
National Heart, Lung, and Blood Institute (NHLBI) |
2017-12-04 | PHASE2 |
| NCT04230499 | ACTIVE_NOT_RECRUITING | Familial Adenomatous Polyposis |
Rapamycin Holdings Inc. |
2021-01-18 | PHASE2 |
| NCT05362994 | UNKNOWN | Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis |
National Taiwan University Hospital |
2022-09-19 | |
| NCT05773326 | TERMINATED | High Grade Glioma; Glioma; Glioma, Malignant; Glioblastoma |
Nader Sanai |
2023-05-15 | EARLY_PHASE1 |
| NCT07302932 | COMPLETED | Metformin, Prediabetes |
Diabetes Foundation, India |
2023-02-01 | |
| NCT05103358 | ACTIVE_NOT_RECRUITING | Tumor; Tumor, Solid; Metastasis; Metastatic Cancer; Cancer; Cancer Metastatic; Tumors; Neoplasms; Neoplasm Metastasis; Solid Tumor; Advanced Solid Tumor; Advanced Cancer; Malignant Solid Tumor; Malignant Solid Neoplasm; Malignant Neoplasm; Malignant Tumor; TSC; TSC1; TSC2; Metastatic Solid Tumor; Metastatic Neoplasm |
Aadi Bioscience, Inc. |
2022-02-15 | PHASE2 |
| NCT03747328 | WITHDRAWN | Leigh Syndrome |
Aadi Bioscience, Inc. |
2022-04-30 | PHASE2 |
| NCT05206084 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease |
Biotyx Medical (Shenzhen) Co., Ltd. |
2022-03-10 | |
| NCT05840510 | TERMINATED | Solid Tumor, Adult; NSCLC; Advanced Cancer; Metastatic Cancer; Malignant Neoplastic Disease |
Mirati Therapeutics Inc. |
2023-08-07 | PHASE1 |
| NCT06022068 | COMPLETED | Alzheimer Disease |
Karolinska Institutet |
2023-09-01 | PHASE1; PHASE2 |
| NCT05548023 | UNKNOWN | Cardiovascular Diseases |
Chinese University of Hong Kong |
2023-12-08 | |
| NCT06345209 | UNKNOWN | Coronary Artery Disease |
BrosMed Medical Co., Ltd |
2024-05 | |
| NCT01428973 | UNKNOWN | Graft-Versus-Host Disease; Hematological Malignancies |
University of Liege |
2011-09 | PHASE2 |
| NCT05625919 | UNKNOWN | Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2022-11-08 | PHASE1; PHASE2 |
| NCT06197022 | UNKNOWN | Coronary Artery Disease |
University National Heart Hospital |
2022-10-01 | |
| NCT06308445 | Not yet recruiting | Familial Adenomatous Polyposis |
University Hospital Toulouse |
2024-08-01 | Phase 2 |
| NCT05205499 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease |
Biotyx Medical (Shenzhen) Co., Ltd. |
2022-03-10 | |
| NCT04406870 | UNKNOWN | Hemangioendothelioma of Liver |
Shanghai Children's Medical Center |
2020-07 | PHASE4 |
| NCT04415476 | WITHDRAWN | Disorder Related to Lung Transplantation; Chronic Rejection of Lung Transplant; Decreased Immunologic Activity |
University of Maryland, Baltimore |
2020-06-30 | PHASE2 |
| NCT05663944 | COMPLETED | Advanced Chronic Liver Disease |
Nottingham University Hospitals NHS Trust |
2022-07-25 | PHASE2 |
| NCT05467397 | ACTIVE_NOT_RECRUITING | Lymphangioleiomyomatosis; Tuberous Sclerosis Complex |
Brigham and Women's Hospital |
2021-08-30 | PHASE1; PHASE2 |
| NCT06279494 | UNKNOWN | Acute Leukemia; Myelodysplastic Syndromes; Severe Aplastic Anemia |
Peking University People's Hospital |
2024-03 | PHASE1; PHASE2 |
| NCT04598815 | UNKNOWN | Graves Ophthalmopathy |
University of Pisa |
2023-06-01 | PHASE2 |
| NCT01203722 | COMPLETED | Hematologic Malignancies |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-09 | PHASE1; PHASE2 |
| NCT05450042 | UNKNOWN | Peripheral Arterial Disease; Flow-mediated Dilation; Drug Eluting Balloon; Infrainguinal Peripheral Arterial Disease |
University Hospital, Essen |
2022-04-06 | |
| NCT05801003 | UNKNOWN | Coronary Artery Disease; Percutaneous Coronary Intervention; Cutting Balloon |
Hospital Universitario La Fe |
2023-02-01 | |
| NCT06310291 | Not yet recruiting | Celiac Disease |
Barinthus Biotherapeutics |
2024-04 | Early Phase 1 |
| NCT05066789 | TERMINATED | Coronary Artery Disease |
Samsung Medical Center |
2022-01-17 | PHASE4 |
| NCT04707209 | COMPLETED | Retinal Astrocytic Hamartoma |
The Hospital for Sick Children |
2020-11-04 | |
| NCT05170828 | WITHDRAWN | Acute Leukemia; Myelodysplastic Syndromes; T-lymphoblastic Lymphoma; Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Acute Biphenotypic Leukemia; Acute Undifferentiated Leukemia |
Ossium Health, Inc. |
2022-09 | PHASE1 |
| NCT04172922 | TERMINATED | Vascular Anomaly |
Nemours Children's Clinic |
2020-04-01 | PHASE1 |
| NCT04736589 | NOT_YET_RECRUITING | Breast Cancer |
Peking Union Medical College |
2021-02-02 | PHASE3 |
| NCT07326735 | COMPLETED | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) |
Frisch Medical Device Private Limited |
2023-01-11 | PHASE4 |
| NCT02105766 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease; Thalassemia; Stem Cell Transplantation; Graft vs Host Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2014-04-21 | PHASE2 |
| NCT05605665 | COMPLETED | Sjögren's Syndrome |
Peking University People's Hospital |
2022-12-05 | PHASE1; PHASE2 |
| NCT04488601 | COMPLETED | Aging |
AgelessRx |
2020-01-01 | PHASE2 |
| NCT04562532 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2021-02-17 | |
| NCT06091332 | Not yet recruiting | Cavernous Malformations|Brain Stem Hemorrhage |
Huashan Hospital |
2023-12-01 | Phase 2 |
| NCT04994561 | WITHDRAWN | Aging |
Vitality in Aging Research Group, Inc. |
2022-06 | PHASE1 |
| NCT05997056 | Recruiting | Neuroendocrine Tumors|NET|Pancreatic Neuroendocrine Tumor|Gastrointestinal Neuroendocrine Tumor|Pulmonary Neuroendocrine Tumor |
Aadi Bioscience Inc. |
2023-11-07 | Phase 2 |
| NCT01850108 | UNKNOWN | Sickle Cell Disease; Hemoglobinopathies |
Vanderbilt-Ingram Cancer Center |
2013-05 | |
| NCT05101005 | UNKNOWN | Coronary Artery Disease; Drug-coated Balloon |
Lepu Medical Technology (Beijing) Co., Ltd. |
2021-10 | |
| NCT04918615 | UNKNOWN | Coronary Artery Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2021-02-28 | |
| NCT04236609 | UNKNOWN | Diabetes; Coronary Artery Disease; Acute Coronary Syndrome |
Concept Medical Inc. |
2020-06-15 | |
| NCT04409912 | UNKNOWN | End Stage Renal Failure on Dialysis; Arteriovenous Graft Occlusion |
Singapore General Hospital |
2021-01-11 | |
| NCT05643872 | RECRUITING | Pachyonychia Congenita |
Palvella Therapeutics, Inc. |
2022-11-15 | PHASE3 |
| NCT06022068 | Enrolling by invitation | Alzheimer Disease |
Karolinska Institutet|Karolinska University Hospital |
2023-09-01 | Phase 1|Phase 2 |
| NCT05532072 | UNKNOWN | Graves Ophthalmopathy |
First Affiliated Hospital Xi'an Jiaotong University |
2022-09 | EARLY_PHASE1 |
| NCT04951050 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease; Coronary Stenosis |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2022-02-28 | |
| NCT04996719 | COMPLETED | Heart Failure |
Mayo Clinic |
2022-05-24 | PHASE1 |
| NCT03192397 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia in Remission; Adult Acute Lymphoblastic Leukemia in Complete Remission; Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission; Chronic Myelomonocytic Leukemia in Remission; Graft Versus Host Disease; Hodgkin Lymphoma; Minimal Residual Disease; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Severe Aplastic Anemia; Waldenstrom Macroglobulinemia |
Roswell Park Cancer Institute |
2017-08-09 | PHASE1; PHASE2 |
| NCT03077542 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2017-04-06 | PHASE1; PHASE2 |
| NCT05180708 | COMPLETED | Pachyonychia Congenita |
Palvella Therapeutics, Inc. |
2021-11-29 | PHASE3 |
| NCT02567435 | ACTIVE_NOT_RECRUITING | Alveolar Rhabdomyosarcoma; Botryoid-Type Embryonal Rhabdomyosarcoma; Embryonal Rhabdomyosarcoma; Rhabdomyosarcoma; Sclerosing Rhabdomyosarcoma; Spindle Cell Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2016-06-01 | PHASE3 |
| NCT04339062 | COMPLETED | Cutaneous Squamous Cell Carcinoma; Advanced Cancer |
Dana-Farber Cancer Institute |
2020-11-03 | PHASE1; PHASE2 |
| NCT04989686 | Recruiting | Immunosuppression |
Children''s Hospital of Philadelphia|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2023-06-08 | -- |
| NCT03500848 | UNKNOWN | Liver Transplantation |
Southern Medical University, China |
2018-05-01 | PHASE2; PHASE3 |
| NCT02766465 | COMPLETED | Sickle Cell Disease |
Medical College of Wisconsin |
2017-03-16 | PHASE2 |
| NCT03908450 | COMPLETED | Coronary Artery Disease |
InnoRa GmbH |
2019-09-25 | |
| NCT01737502 | COMPLETED | Extensive Stage Small Cell Lung Carcinoma; Lung Adenocarcinoma; Recurrent Non-Small Cell Lung Carcinoma; Recurrent Small Cell Lung Carcinoma; Squamous Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer |
Mayo Clinic |
2014-05-14 | PHASE1; PHASE2 |
| NCT03363763 | TERMINATED | Angiofibroma of Face; Tuberous Sclerosis |
Aucta Pharmaceuticals, Inc |
2017-04-12 | PHASE2 |
| NCT04893486 | COMPLETED | BCCs in Gorlin Syndrome Patients |
Palvella Therapeutics, Inc. |
2021-05-06 | PHASE2 |
| NCT02722668 | COMPLETED | Acute Leukemia; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia/Lymphoma; Burkitt's Lymphoma; Natural Killer Cell Malignancies; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Large-cell Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Relapsed Chronic Lymphocytic Leukemia; Relapsed Small Lymphocytic Lymphoma; Marginal Zone B-cell Lymphoma; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle-cell Lymphoma; Prolymphocytic Leukemia; Bone Marrow Failure Syndromes; Myeloproliferative Neoplasms/Myelofibrosis; Biphenotypic/Undifferentiated/Prolymphocytic Leukemias; MRD Positive Leukemia; Leukemia or MDS in Aplasia; Relapsed T-Cell Lymphoma; Relapsed Multiple Myeloma; Plasma Cell Leukemia |
Masonic Cancer Center, University of Minnesota |
2017-05-15 | PHASE2 |
| NCT03158389 | COMPLETED | Glioblastoma, Adult |
University Hospital Heidelberg |
2018-05-07 | PHASE1; PHASE2 |
| NCT04176380 | COMPLETED | Relapsed, Refractory Multiple Myeloma |
Rapa Therapeutics LLC |
2020-12-02 | PHASE2 |
| NCT00061568 | UNKNOWN | Congenital Hemolytic Anemia; Sickle Cell Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2004-07-16 | PHASE1; PHASE2 |
| NCT03531281 | WITHDRAWN | Hematopoietic and Lymphoid Cell Neoplasm; Hematopoietic Cell Transplantation Recipient |
City of Hope Medical Center |
2018-12-30 | PHASE1 |
| NCT05190627 | UNKNOWN | Lymphangioleiomyomatosis |
Institut d'Investigació Biomèdica de Bellvitge |
2021-11-01 | PHASE2 |
| NCT04077515 | COMPLETED | Hemangioma; Kaposiform Hemangioendothelioma |
Children's Hospital of Fudan University |
2019-05-01 | PHASE4 |
| NCT04598204 | UNKNOWN | Vascular Anomalies |
Zhujiang Hospital |
2017-12-01 | PHASE2; PHASE3 |
| NCT03383380 | COMPLETED | Activated PI3K-delta Syndrome; Immunodeficiency Primary |
Children's Hospital of Fudan University |
2017-12-01 | PHASE1; PHASE2 |
| NCT04348292 | TERMINATED | Lung Non-Small Cell Carcinoma; Stage I Lung Cancer AJCC v8; Stage IA1 Lung Cancer AJCC v8; Stage IA2 Lung Cancer AJCC v8; Stage IA3 Lung Cancer AJCC v8; Stage IB Lung Cancer AJCC v8; Stage II Lung Cancer AJCC v8; Stage IIA Lung Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8 |
Emory University |
2021-01-22 | PHASE1 |
| NCT01903473 | TERMINATED | Chronic Graft-Versus-Host Disease; Acute Graft-Versus-Host Disease; Steroid Refractory Graft-Versus-Host Disease |
University of Liege |
2013-07 | PHASE2 |
| NCT03826628 | COMPLETED | Facial Angiofibroma; Tuberous Sclerosis |
Dermatology Specialties Limited Partnership |
2019-07-28 | PHASE2; PHASE3 |
| NCT03463265 | COMPLETED | High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma |
Aadi Bioscience, Inc. |
2018-08-01 | PHASE2 |
| NCT02978456 | COMPLETED | Coronary Disease; Coronary Stenoses |
CHEOL WHAN LEE, M.D., Ph.D |
2017-02-23 | |
| NCT03646240 | COMPLETED | Epilepsy Intractable |
Seattle Children's Hospital |
2018-07-31 | PHASE1 |
| NCT02587325 | COMPLETED | Pulmonary Hypertension |
Aadi Bioscience, Inc. |
2017-04-01 | PHASE1 |
| NCT03439462 | COMPLETED | Colorectal Cancer Metastatic |
Aadi Bioscience, Inc. |
2018-07-01 | PHASE1; PHASE2 |
| NCT04157153 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease |
Biotronik AG |
2020-04-27 | |
| NCT04594889 | UNKNOWN | Critical Limb Ischemia; Drug Effect |
Ospedale San Donato |
2020-10-14 | |
| NCT04179045 | UNKNOWN | Coronary Artery Disease |
Shanghai Bio-heart Biological Technology Co., Ltd. |
2021-03-01 | |
| NCT03500367 | UNKNOWN | Uterine Fibroids |
Peking Union Medical College Hospital |
2018-01-01 | PHASE4 |
| NCT04247750 | UNKNOWN | Beta-Thalassemia |
Università degli Studi di Ferrara |
2021-04-13 | PHASE2 |
| NCT04608448 | COMPLETED | Aging; Epigenetics; Inflammatory Mediators |
The University of Texas Health Science Center at San Antonio |
2021-04-28 | EARLY_PHASE1 |
| NCT02975882 | COMPLETED | Childhood Solid Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Primary Central Nervous System Neoplasm; Refractory Malignant Solid Neoplasm; Refractory Primary Central Nervous System Neoplasm |
Children's Oncology Group |
2017-08-15 | PHASE1 |
| NCT02642094 | TERMINATED | Cancer of Breast |
LuZhe Sun |
2016-07 | PHASE2 |
| NCT03298958 | WITHDRAWN | Bladder Cancer |
The University of Texas Health Science Center at San Antonio |
2018-11-01 | PHASE3 |
| NCT04200911 | COMPLETED | Cognitive Impairment, Mild; Alzheimer Disease |
The University of Texas Health Science Center at San Antonio |
2020-06-01 | EARLY_PHASE1 |
| NCT03767660 | UNKNOWN | Blue Rubber Bleb Nevus Syndrome; Venous Malformation |
Peking Union Medical College Hospital |
2018-07-31 | PHASE4 |
| NCT03781050 | UNKNOWN | Peutz-Jeghers Syndrome |
Peking Union Medical College Hospital |
2018-09-16 | PHASE4 |
| NCT02109744 | COMPLETED | Acute Myelogenous Leukemia |
University of Rochester |
2014-03 | PHASE1; PHASE2 |
| NCT04482712 | WITHDRAWN | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS); Respiratory Failure; Sars-CoV2 |
The University of Texas Health Science Center at San Antonio |
2021-04 | PHASE1; PHASE2 |
| NCT03188068 | COMPLETED | Kaposiform Hemangioendothelioma; Kasabach Merritt Phenomenon |
West China Hospital |
2017-06-01 | PHASE2 |
| NCT02867800 | COMPLETED | Sickle Cell Disease; Graft Versus Host Disease |
Monica Bhatia |
2016-07 | PHASE1 |
| NCT03512756 | TERMINATED | Pancreatic Cancer |
Tyme, Inc |
2018-03-27 | PHASE2; PHASE3 |
| NCT01265030 | COMPLETED | Desmoid Tumor |
MaineHealth |
2014-02 | PHASE1; PHASE2 |
| NCT03716011 | UNKNOWN | Coronary Artery Disease |
JW Medical Systems Ltd |
2018-12-20 | |
| NCT04534257 | UNKNOWN | Critical Lower Limb Ischemia; Peripheral Artery Disease |
Singapore General Hospital |
2020-09-09 | |
| NCT03916432 | UNKNOWN | Coronary Artery Disease |
Xijing Hospital |
2018-12-01 | |
| NCT03190174 | COMPLETED | Ewing Sarcoma; PEComa; Epithelioid Sarcoma; Desmoid Tumor; Chordoma; Non Small Cell Lung Cancer; Urothelial Carcinoma; Melanoma; Renal Cell Carcinoma; Squamous Cell Carcinoma; Hepatocellular Carcinoma; Classical Hodgkin Lymphoma; Colorectal Cancer; MTOR Activating Mutation |
Sarcoma Oncology Research Center, LLC |
2017-08-24 | PHASE1; PHASE2 |
| NCT03721614 | UNKNOWN | Coronary Artery Disease |
Meril Life Sciences Pvt. Ltd. |
2019-09-15 | |
| NCT03667313 | COMPLETED | Coronary Restenosis |
University Hospital Ostrava |
2018-10-01 | PHASE3 |
| NCT03657420 | WITHDRAWN | Multiple Myeloma |
Massachusetts General Hospital |
2019-05-30 | PHASE1 |
| NCT02240407 | COMPLETED | Pompe Disease |
University of Florida |
2017-10-17 | PHASE1 |
| NCT04591938 | UNKNOWN | Percutaneous Coronary Intervention; Myocardial Revascularization; Tomography, Optical Coherence |
Joost Daemen |
2019-10-01 | |
| NCT02513303 | COMPLETED | Complication of Renal Dialysis; End Stage Renal Disease; End Stage Kidney Disease; ESRD; Chronic Kidney Failure; Complication of Hemodialysis; Vascular Access Complication; Arteriovenous Fistula |
Vascular Therapies, Inc. |
2015-11 | PHASE3 |
| NCT02596828 | COMPLETED | Pineoblastoma |
University of Regensburg |
2016-04 | PHASE2 |
| NCT03583307 | COMPLETED | Vascular Anomaly |
West China Hospital |
2018-06-01 | |
| NCT01266057 | COMPLETED | Advanced Cancers |
M.D. Anderson Cancer Center |
2011-04-28 | PHASE1 |
| NCT03670030 | TERMINATED | Neuroendocrine Tumors |
Robert Ramirez |
2018-11-05 | PHASE2 |
| NCT03359538 | COMPLETED | Amyotrophic Lateral Sclerosis |
Azienda Ospedaliero-Universitaria di Modena |
2017-09-19 | PHASE2 |
| NCT04150016 | UNKNOWN | Drug-eluting Stents; Percutaneous Coronary Intervention; Optical Coherence Tomography; ST-Elevation Myocardial Infarction |
Xijing Hospital |
2019-03-08 | |
| NCT03454724 | UNKNOWN | Coronary Artery Disease |
Meril Life Sciences Pvt. Ltd. |
2020-01-01 | |
| NCT02768116 | UNKNOWN | Coronary Heart Disease |
Beijing Anzhen Hospital |
2016-06 | |
| NCT04461340 | UNKNOWN | COVID 19 |
Alexandria University |
2020-08-15 | PHASE2 |
| NCT00352976 | COMPLETED | Fanconi Anemia |
Masonic Cancer Center, University of Minnesota |
2006-05-18 | PHASE2; PHASE3 |
| NCT02675153 | UNKNOWN | Crohn's Diseases |
The Second Hospital of Nanjing Medical University |
2015-04-01 | |
| NCT01467986 | COMPLETED | Neuroblastoma Recurrent |
University of Regensburg |
2013-08 | PHASE2 |
| NCT02908035 | UNKNOWN | Chronic Limb Ischemia |
Mercator MedSystems, Inc. |
2017-03-03 | PHASE2 |
| NCT03284255 | UNKNOWN | Coronary Artery Disease; Antineoplastic Agents |
Shanghai Bio-heart Biological Technology Co., Ltd. |
2017-09-11 | |
| NCT04017364 | COMPLETED | Coronary Artery Disease |
InnoRa GmbH |
2019-07-01 | |
| NCT04049552 | COMPLETED | Keloid |
The University of Texas Health Science Center at San Antonio |
2020-01-24 | EARLY_PHASE1 |
| NCT03242096 | COMPLETED | Coronary Restenosis |
InnoRa GmbH |
2017-07-21 | |
| NCT03190473 | TERMINATED | Acute Coronary Syndrome |
Svelte Medical Systems, Inc. |
2018-01-02 | |
| NCT02565901 | TERMINATED | Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v7; Metastatic Malignant Neoplasm in the Bone |
University of Washington |
2016-02-29 | PHASE1; PHASE2 |
| NCT03112603 | COMPLETED | Graft-versus-host Disease (GVHD) |
Incyte Corporation |
2017-06-29 | PHASE3 |
| NCT03942926 | UNKNOWN | Plastic Bronchitis |
Peking Union Medical College Hospital |
2019-05-06 | PHASE2 |
| NCT04115800 | COMPLETED | Dry Eye |
Instituto de Oftalmología Fundación Conde de Valenciana |
2019-10-02 | EARLY_PHASE1 |
| NCT02917096 | COMPLETED | Primary Myelofibrosis; Secondary Myelofibrosis |
City of Hope Medical Center |
2016-11-13 | PHASE1 |
| NCT03486366 | UNKNOWN | Epilepsy |
Medical University of Warsaw |
2017-04-01 | |
| NCT01885689 | ACTIVE_NOT_RECRUITING | Adult Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission; Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Therapy-Related Myelodysplastic Syndrome |
City of Hope Medical Center |
2014-02-10 | PHASE2 |
| NCT03732248 | COMPLETED | Alcohol Use Disorder; Alcohol Dependence |
Medical University of South Carolina |
2018-07-12 | PHASE1 |
| NCT04161144 | COMPLETED | Smoking Cessation; Smoking, Cigarette; Nicotine Dependence |
Medical University of South Carolina |
2018-10-01 | PHASE2 |
| NCT01822015 | COMPLETED | Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Untreated Adult Acute Myeloid Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2013-03-15 | EARLY_PHASE1 |
| NCT03618355 | COMPLETED | Prostate Cancer |
Rapamycin Holdings, Inc. dba Emtora Biosciences |
2018-08-28 | PHASE1 |
| NCT02009332 | COMPLETED | Non-muscle Invasive Bladder Cancer (NMIBC) |
Aadi Bioscience, Inc. |
2014-04-09 | PHASE1; PHASE2 |
| NCT02753309 | COMPLETED | Bladder Cancer |
The University of Texas Health Science Center at San Antonio |
2016-06 | EARLY_PHASE1 |
| NCT03578432 | TERMINATED | Salivary Gland Dysfunction; Xerostomia; Head and Neck Cancer |
University of Arizona |
2018-05-04 | EARLY_PHASE1 |
| NCT00426517 | COMPLETED | Inherited Immune Deficiencies |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-01-19 | EARLY_PHASE1 |
| NCT02730923 | UNKNOWN | Endometrial Carcinoma; Metastatic Carcinoma; Hormone Receptor Positive Tumor |
Centre Leon Berard |
2016-04 | PHASE1; PHASE2 |
| NCT02110069 | TERMINATED | Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted Angioma |
Boston Children's Hospital |
2017-06-14 | PHASE2 |
| NCT03040934 | UNKNOWN | Drug-Eluting Stents; Percutaneous Coronary Intervention; Tomography, Optical Coherence |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2017-11-10 | |
| NCT03027856 | COMPLETED | Coronary Artery Disease |
Aarhus University Hospital Skejby |
2016-09 | |
| NCT02400632 | COMPLETED | Coronary Artery Disease |
Scitech Produtos Medicos SA |
2015-06 | PHASE3 |
| NCT02990312 | WITHDRAWN | Hiv; Kidney Transplant; HIV Reservoir; CCR5 |
University of Maryland, Baltimore |
2017-05-01 | PHASE4 |
| NCT03047980 | COMPLETED | Sturge-Weber Syndrome |
Anne Comi, MD |
2017-01 | PHASE2; PHASE3 |
| NCT03016715 | UNKNOWN | Epidermolysis Bullosa Simplex; Epidermolysis Bullosa Simplex Kobner; Weber-Cockayne Syndrome |
Premier Specialists, Australia |
2016-05 | PHASE2 |
| NCT02579031 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome |
Insel Gruppe AG, University Hospital Bern |
2016-04 | |
| NCT03616132 | UNKNOWN | Single Coronary Vessel Disease |
Lifetech Scientific (Shenzhen) Co., Ltd. |
2018-03-28 | |
| NCT03072485 | COMPLETED | Aging |
Anne Chang |
2017-03-01 | PHASE1 |
| NCT03963024 | TERMINATED | Irradiated Bone Marrow; Transplant-Related Hematologic Malignancy; Leukemia, Acute; Multiple Myeloma; Graft Vs Host Disease |
IRCCS San Raffaele |
2014-02-12 | PHASE1 |
| NCT02959918 | COMPLETED | Gout Chronic; Hyperuricemia |
Selecta Biosciences, Inc. |
2016-10 | PHASE2 |
| NCT02803892 | COMPLETED | Diabetes Mellitus, Type 1 |
Piemonti Lorenzo |
2016-05 | PHASE2 |
| NCT01251575 | COMPLETED | Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Adult Diffuse Large B-Cell Lymphoma; Adult Myelodysplastic Syndrome; Adult Non-Hodgkin Lymphoma; Aggressive Non-Hodgkin Lymphoma; Childhood Acute Lymphoblastic Leukemia; Childhood Acute Myeloid Leukemia; Childhood Diffuse Large B-Cell Lymphoma; Childhood Myelodysplastic Syndrome; Childhood Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid Cell Neoplasm; Mantle Cell Lymphoma; Plasma Cell Myeloma; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia; Waldenstrom Macroglobulinemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma |
Fred Hutchinson Cancer Center |
2010-12-01 | PHASE2 |
| NCT01051557 | COMPLETED | Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Oligodendroglioma; Recurrent Adult Brain Neoplasm |
National Cancer Institute (NCI) |
2010-01-27 | PHASE1; PHASE2 |
| NCT02623140 | UNKNOWN | Ischaemic Heart Disease |
Odense University Hospital |
2015-12 | PHASE4 |
| NCT02870140 | COMPLETED | Coronary Stenosis |
ECRI bv |
2016-10-21 | |
| NCT03421756 | TERMINATED | Sickle Cell Disease |
Kathleen Dorritie |
2018-03-29 | EARLY_PHASE1 |
| NCT02874924 | COMPLETED | Aging |
The University of Texas Health Science Center at San Antonio |
2016-06 | PHASE2 |
| NCT02915107 | UNKNOWN | Acute Myocardial Infarction |
Odense University Hospital |
2016-09 | |
| NCT01517243 | COMPLETED | Metastatic Renal Cell Carcinoma |
Dartmouth-Hitchcock Medical Center |
2010-09-22 | PHASE2 |
| NCT00409994 | COMPLETED | Rectum Cancer |
Maastricht Radiation Oncology |
2006-09 | PHASE1; PHASE2 |
| NCT03026465 | COMPLETED | Coronary Artery Disease |
Fundacion Investigacion Interhospitalaria Cardiovascular |
2017-02-16 | PHASE4 |
| NCT01976390 | COMPLETED | Renal Failure |
Ohio State University |
2013-10-01 | |
| NCT01653067 | UNKNOWN | Diffuse Large B-Cell Lymphoma |
Mathias Witzens-Harig |
2012-09 | PHASE2 |
| NCT03161340 | COMPLETED | Recurrent Implantation Failure |
Mehdi Yousefi |
2017-07-11 | PHASE2 |
| NCT02505893 | COMPLETED | Diabetes Mellitus, Type 1 |
Ospedale San Raffaele |
2015-04 | PHASE2 |
| NCT02365415 | WITHDRAWN | Peripheral Pulmonary Stenosis; In-stent Stenosis |
Boston Children's Hospital |
2015-02 | PHASE2 |
| NCT02048384 | COMPLETED | Metastatic Pancreatic Adenocarcinoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2014-06-10 | PHASE1 |
| NCT02481453 | COMPLETED | Inclusion Body Myositis (IBM) |
Institut National de la Santé Et de la Recherche Médicale, France |
2015-07-15 | PHASE2; PHASE3 |
| NCT01076543 | COMPLETED | AIDS-Related Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Waldenstrom Macroglobulinemia |
National Cancer Institute (NCI) |
2010-04-15 | PHASE1; PHASE2 |
| NCT01756118 | COMPLETED | Acute Lymphoblastic Leukemia; Leukemia, Myelocytic, Acute; Chronic Myelogenous Leukemia With Crisis of Blast Cells |
Goethe University |
2012-06 | PHASE1 |
| NCT03103893 | COMPLETED | Dermal Atrophy |
Drexel University |
2017-09-25 | PHASE1; PHASE2 |
| NCT00610493 | COMPLETED | Advanced Cancer |
M.D. Anderson Cancer Center |
2008-01-25 | PHASE1 |
| NCT02440789 | COMPLETED | HIV-1 Infection |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2015-12-21 | PHASE1; PHASE2 |
| NCT02663323 | UNKNOWN | Coronary Artery Disease |
Meril Life Sciences Pvt. Ltd. |
2016-02-02 | |
| NCT02343718 | COMPLETED | Recurrent Lymphoma; Refractory Lymphoma; Solid Tumours; Central Nervous System |
Canadian Cancer Trials Group |
2015-06-24 | PHASE1 |
| NCT02449564 | COMPLETED | Solid Tumor |
Samsung Medical Center |
2014-11-24 | |
| NCT01078142 | COMPLETED | Follicular Lymphoma; Mantle Cell Lymphoma |
Georg Hess, MD |
2010-02-02 | PHASE1; PHASE2 |
| NCT02112981 | UNKNOWN | Coronary Artery Disease |
Meril Life Sciences Pvt. Ltd. |
2014-11-05 | |
| NCT02646319 | COMPLETED | Advanced Malignant Neoplasm; Cervical Squamous Cell Carcinoma; Endometrial Carcinoma; Malignant Uterine Neoplasm; Recurrent Bladder Carcinoma; Recurrent Breast Carcinoma; Recurrent Cervical Carcinoma; Recurrent Head and Neck Carcinoma; Recurrent Malignant Neoplasm; Recurrent Ovarian Carcinoma; Recurrent Prostate Carcinoma; Recurrent Renal Cell Carcinoma; Solid Neoplasm; Stage III Bladder Cancer; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage IIIA Breast Cancer; Stage IIIA Cervical Cancer; Stage IIIA Ovarian Cancer; Stage IIIB Breast Cancer; Stage IIIB Cervical Cancer; Stage IIIB Ovarian Cancer; Stage IIIC Breast Cancer; Stage IIIC Ovarian Cancer; Stage IV Breast Cancer; Stage IV Ovarian Cancer; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IVA Bladder Cancer; Stage IVA Cervical Cancer; Stage IVB Bladder Cancer; Stage IVB Cervical Cancer |
Mayo Clinic |
2016-01 | EARLY_PHASE1 |
| NCT02305472 | UNKNOWN | Coronary Artery Disease |
Lepu Medical Technology (Beijing) Co., Ltd. |
2014-11 | |
| NCT01239368 | TERMINATED | Myeloma, Plasma-Cell; Myeloma-Multiple; Myelomatosis |
National Cancer Institute (NCI) |
2010-11-10 | PHASE1; PHASE2 |
| NCT02996318 | COMPLETED | DES In-stent Stenosis |
InnoRa GmbH |
2015-12-01 | |
| NCT00565773 | COMPLETED | Organ Transplantation |
Allan D Kirk, MD, PhD |
2007-12 | PHASE2 |
| NCT02389946 | COMPLETED | Coronary Artery Disease; Atherosclerosis, Coronary; Myocardial Ischemia; Ischemic Heart Disease; Acute Coronary Syndrome; Angina Pectoris |
Biotronik, Inc. |
2015-05 | |
| NCT02732899 | COMPLETED | Exudative Age Related Macular Degeneration |
Maturi, Raj K., M.D., P.C. |
2016-04 | PHASE2 |
| NCT01106833 | COMPLETED | Chronic GVHD |
Medical College of Wisconsin |
2010-04 | PHASE2; PHASE3 |
| NCT02385279 | COMPLETED | Coronary Stenosis |
ECRI bv |
2015-03-20 | |
| NCT01548807 | COMPLETED | Prostate Cancer Patients With Detectable PSA Following Prostatectomy |
Abramson Cancer Center at Penn Medicine |
2010-09 | PHASE1 |
| NCT02357342 | COMPLETED | Age-Related Macular Degeneration |
Maturi, Raj K., M.D., P.C. |
2015-04 | PHASE2 |
| NCT01658007 | TERMINATED | Relapsed Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Lymphoblastic Lymphoma |
Children's Hospital Medical Center, Cincinnati |
2012-08 | EARLY_PHASE1 |
| NCT02844270 | UNKNOWN | Heart Diseases |
Shanghai Bio-heart Biological Technology Co., Ltd. |
2016-08-09 | |
| NCT02496169 | UNKNOWN | Coronary Artery Disease |
Eucatech AG |
2015-07 | |
| NCT01649609 | COMPLETED | BK Viremia; BK Nephropathy |
Columbia University |
2012-03 | |
| NCT01188889 | WITHDRAWN | Chronic Myeloid Leukemia |
University of Michigan Rogel Cancer Center |
2013-09 | PHASE1; PHASE2 |
| NCT01326468 | WITHDRAWN | Head and Neck Cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2011-12-08 | |
| NCT02145559 | COMPLETED | Breast Neoplasms; Lung Neoplasms; Cancer of Liver; Lymphoma; Cancer of Kidney |
University of Chicago |
2014-04 | PHASE1 |
| NCT03140449 | COMPLETED | Facial Angiofibroma |
National Taiwan University Hospital |
2013-09-05 | PHASE3 |
| NCT02236975 | COMPLETED | Coronary Artery Disease |
Sino Medical Sciences Technology Inc. |
2015-04 | PHASE2; PHASE3 |
| NCT02520180 | COMPLETED | Coronary Artery Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2015-12 | |
| NCT00838955 | TERMINATED | Hodgkin's Lymphoma |
Loyola University |
2009-01 | PHASE2 |
| NCT02528877 | WITHDRAWN | Acute Myeloid Leukemia in Remission; Primary Myelofibrosis; Primary Myelofibrosis, Prefibrotic Stage; Secondary Acute Myeloid Leukemia; Secondary Myelofibrosis |
City of Hope Medical Center |
2015-11 | PHASE1 |
| NCT01938573 | COMPLETED | Recurrent Bladder Carcinoma; Stage II Bladder Cancer; Stage III Bladder Cancer; Stage IV Bladder Cancer |
University of Washington |
2013-10 | PHASE1; PHASE2 |
| NCT01582048 | TERMINATED | Patients Receiving Mismatched Allogeneic HCT |
Prof. Dr. med. Wolfgang Bethge |
2012-04 | PHASE2 |
| NCT01924962 | COMPLETED | Coronary Heart Disease |
University Heart Center Freiburg - Bad Krozingen |
2008-05-28 | |
| NCT01925027 | UNKNOWN | Coronary Artery Disease |
Lepu Medical Technology (Beijing) Co., Ltd. |
2013-07 | PHASE4 |
| NCT01522820 | COMPLETED | Anaplastic Astrocytoma; Anaplastic Oligoastrocytoma; Anaplastic Oligodendroglioma; Estrogen Receptor Negative; Estrogen Receptor Positive; Glioblastoma; Hormone-Resistant Prostate Cancer; Metastatic Prostate Carcinoma; Metastatic Renal Cell Cancer; Recurrent Adult Brain Neoplasm; Recurrent Bladder Carcinoma; Recurrent Breast Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Esophageal Carcinoma; Recurrent Gastric Carcinoma; Recurrent Hepatocellular Carcinoma; Recurrent Lung Carcinoma; Recurrent Melanoma; Recurrent Ovarian Carcinoma; Recurrent Prostate Carcinoma; Recurrent Renal Cell Carcinoma; Recurrent Uterine Corpus Carcinoma; Resectable Hepatocellular Carcinoma; Sarcoma; Stage IA Breast Cancer; Stage IA Ovarian Cancer; Stage IA Uterine Corpus Cancer; Stage IB Breast Cancer; Stage IB Ovarian Cancer; Stage IB Uterine Corpus Cancer; Stage IC Ovarian Cancer; Stage II Uterine Corpus Cancer; Stage IIA Breast Cancer; Stage IIA Lung Carcinoma; Stage IIA Ovarian Cancer; Stage IIB Breast Cancer; Stage IIB Esophageal Cancer; Stage IIB Lung Carcinoma; Stage IIB Ovarian Cancer; Stage IIB Skin Melanoma; Stage IIC Ovarian Cancer; Stage IIC Skin Melanoma; Stage IIIA Breast Cancer; Stage IIIA Esophageal Cancer; Stage IIIA Lung Carcinoma; Stage IIIA Ovarian Cancer; Stage IIIA Skin Melanoma; Stage IIIA Uterine Corpus Cancer; Stage IIIB Breast Cancer; Stage IIIB Esophageal Cancer; Stage IIIB Ovarian Cancer; Stage IIIB Skin Melanoma; Stage IIIB Uterine Corpus Cancer; Stage IIIC Breast Cancer; Stage IIIC Esophageal Cancer; Stage IIIC Ovarian Cancer; Stage IIIC Skin Melanoma; Stage IIIC Uterine Corpus Cancer; Stage IV Bladder Urothelial Carcinoma; Stage IV Esophageal Cancer; Stage IV Ovarian Cancer; Stage IV Prostate Cancer; Stage IV Skin Melanoma; Stage IVA Uterine Corpus Cancer; Stage IVB Uterine Corpus Cancer |
Roswell Park Cancer Institute |
2012-03 | PHASE1 |
| NCT01111825 | COMPLETED | Breast Cancer |
Puma Biotechnology, Inc. |
2010-04 | PHASE1; PHASE2 |
| NCT02208791 | UNKNOWN | Kidney Transplantation |
University of Sao Paulo General Hospital |
2014-07 | PHASE4 |
| NCT01318915 | TERMINATED | Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-07-25 | EARLY_PHASE1 |
| NCT02328781 | COMPLETED | Vertebrobasilar Insufficiency |
Zhongrong Miao |
2014-07-17 | |
| NCT02123966 | TERMINATED | Chronic Graft-versus-Host-Disease; Oral Mucosal Disease Due to Graft-versus-host Disease |
Dana-Farber Cancer Institute |
2014-07 | PHASE2 |
| NCT00533442 | COMPLETED | Type 1 Diabetes |
University of Miami |
2000-09 | PHASE2 |
| NCT01183663 | COMPLETED | Advanced Cancers |
M.D. Anderson Cancer Center |
2010-08 | PHASE1 |
| NCT01374750 | COMPLETED | Hepatocellular Carcinoma |
Seoul National University Hospital |
2010-05 | PHASE2 |
| NCT01687673 | COMPLETED | Hepatocellular Carcinoma |
University of California, San Francisco |
2012-10-05 | PHASE2 |
| NCT01510119 | COMPLETED | Metastatic Clear Cell Renal Cell Carcinoma |
Abramson Cancer Center at Penn Medicine |
2011-09 | PHASE1; PHASE2 |
| NCT01689987 | COMPLETED | Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
OHSU Knight Cancer Institute |
2012-09 | PHASE1 |
| NCT00392951 | COMPLETED | Autoimmune Pancytopenia; Autoimmune Lymphoproliferative Syndrome (ALPS); Evans Syndrome; Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune; Autoimmune Neutropenia; Lupus Erythematosus, Systemic; Inflammatory Bowel Disease; Rheumatoid Arthritis |
Children's Hospital of Philadelphia |
2006-12 | PHASE1; PHASE2 |
| NCT01811667 | COMPLETED | Cardiovascular Abnormalities |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2012-05 | PHASE3 |
| NCT01680952 | COMPLETED | Kidney Transplant Patients |
Yonsei University |
2012-09 | PHASE4 |
| NCT02688842 | COMPLETED | Coronary Heart Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2014-05 | |
| NCT00830466 | COMPLETED | Port Wine Stain |
University of California, Irvine |
2008-12 | PHASE1 |
| NCT00779194 | COMPLETED | Systemic Lupus Erythematosus (SLE) |
State University of New York - Upstate Medical University |
2008-10 | PHASE2 |
| NCT02597283 | WITHDRAWN | Coronary Artery Disease |
Nanjing First Hospital, Nanjing Medical University |
2015-12 | |
| NCT02360020 | COMPLETED | Coronary Atherosclerosis Due to Calcified Coronary Lesion; Chronic Total Occlusion of Coronary Artery |
Clinica Mediterranea |
2014-08 | PHASE4 |
| NCT01649960 | COMPLETED | Aging; CAD |
Mayo Clinic |
2012-08 | PHASE1 |
| NCT01180049 | COMPLETED | Non-Hodgkin's Lymphoma |
Pfizer |
2011-03 | PHASE4 |
| NCT01625156 | COMPLETED | Adult Solid Neoplasm |
National Cancer Institute (NCI) |
2012-05 | PHASE1 |
| NCT01946529 | COMPLETED | Desmoplastic Small Round Cell Tumor; Ewing Sarcoma of Bone or Soft Tissue; Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
St. Jude Children's Research Hospital |
2013-12-27 | PHASE2 |
| NCT00997763 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2008-07 | PHASE4 |
| NCT01396408 | ACTIVE_NOT_RECRUITING | Advanced Rare Tumours |
Canadian Cancer Trials Group |
2012-02-09 | PHASE2 |
| NCT01093391 | COMPLETED | Coronary Artery Disease |
Scitech Produtos Medicos SA |
2010-11 | PHASE3 |
| NCT00923845 | COMPLETED | Renal Cell Carcinoma; Graft-Versus-Host Disease; Engraftment Syndrome |
National Cancer Institute (NCI) |
2008-03-01 | PHASE2 |
| NCT01195922 | COMPLETED | Mouth Neoplasms; Head and Neck Neoplasms; Tongue Neoplasms; Carcinoma, Squamous Cell |
National Institute of Dental and Craniofacial Research (NIDCR) |
2010-08 | PHASE1; PHASE2 |
| NCT01222715 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Pleomorphic Rhabdomyosarcoma; Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2010-10 | PHASE2 |
| NCT02724332 | COMPLETED | Hepatocellular Carcinoma; Rapamycin |
Eastern Hepatobiliary Surgery Hospital |
2012-11 | PHASE1 |
| NCT01798446 | COMPLETED | Renal Cell Carcinoma; Nonclear Cell; Temsirolimus Resistance |
Seoul National University Hospital |
2013-02 | PHASE2 |
| NCT01675947 | TERMINATED | Geographic Atrophy |
National Eye Institute (NEI) |
2012-02 | PHASE2 |
| NCT01814059 | TERMINATED | Eosinophilic Gastroenteritis; Eosinophilic Esophagitis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-03-07 | PHASE1 |
| NCT00782275 | COMPLETED | Renal Cell Carcinoma; Kidney Cancer |
Beth Israel Deaconess Medical Center |
2009-04 | PHASE2 |
| NCT01403415 | COMPLETED | Childhood B Acute Lymphoblastic Leukemia; Childhood T Acute Lymphoblastic Leukemia; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2011-09 | PHASE1 |
| NCT01843998 | WITHDRAWN | Cutaneous T-cell Lymphoma (CTCL) |
Stefan Schieke MD |
2014-02 | PHASE2 |
| NCT01536054 | COMPLETED | Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer; Stage IIA Fallopian Tube Cancer; Stage IIA Ovarian Epithelial Cancer; Stage IIA Primary Peritoneal Cavity Cancer; Stage IIB Fallopian Tube Cancer; Stage IIB Ovarian Epithelial Cancer; Stage IIB Primary Peritoneal Cavity Cancer; Stage IIC Fallopian Tube Cancer; Stage IIC Ovarian Epithelial Cancer; Stage IIC Primary Peritoneal Cavity Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Epithelial Cancer; Stage IIIA Primary Peritoneal Cavity Cancer; Stage IIIB Fallopian Tube Cancer; Stage IIIB Ovarian Epithelial Cancer; Stage IIIB Primary Peritoneal Cavity Cancer; Stage IIIC Fallopian Tube Cancer; Stage IIIC Ovarian Epithelial Cancer; Stage IIIC Primary Peritoneal Cavity Cancer; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Primary Peritoneal Cavity Cancer |
Roswell Park Cancer Institute |
2012-08-20 | PHASE1 |
| NCT01206140 | COMPLETED | Recurrent Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma |
National Cancer Institute (NCI) |
2010-10 | PHASE2 |
| NCT00891696 | COMPLETED | Sarcopenia |
The University of Texas Medical Branch, Galveston |
2009-04 | PHASE1 |
| NCT00993343 | COMPLETED | Graft-versus-host Disease; Survival |
Karolinska Institutet |
2007-09 | PHASE3 |
| NCT01842594 | TERMINATED | Sarcoma |
Shin Kong Wu Ho-Su Memorial Hospital |
2012-08 | PHASE2 |
| NCT01196429 | COMPLETED | Ovarian Clear Cell Cystadenocarcinoma; Stage III Ovarian Cancer; Stage IV Ovarian Cancer |
National Cancer Institute (NCI) |
2010-08 | PHASE2 |
| NCT01381692 | COMPLETED | Recurrent Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma |
National Cancer Institute (NCI) |
2011-07-20 | PHASE1; PHASE2 |
| NCT02429973 | COMPLETED | Osteosarcoma |
Broto, Javier Martín, M.D. |
2012-07 | PHASE2 |
| NCT02076516 | UNKNOWN | Coronary Artery Disease |
Alvimedica |
2013-10 | PHASE3 |
| NCT01054313 | COMPLETED | Advanced Cancer |
M.D. Anderson Cancer Center |
2010-01 | PHASE1 |
| NCT01313923 | TERMINATED | Pemphigus |
University of California, Irvine |
2011-02 | EARLY_PHASE1 |
| NCT00602693 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2007-07-23 | PHASE1 |
| NCT02215720 | COMPLETED | Patients With Advanced or Metastatic Solid Tumors |
Gustave Roussy, Cancer Campus, Grand Paris |
2011-04-26 | PHASE1 |
| NCT00993499 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
Boehringer Ingelheim |
2009-10 | PHASE1 |
| NCT01206036 | COMPLETED | Prostatic Neoplasms |
Central European Society for Anticancer Drug Research |
2010-07 | PHASE1; PHASE2 |
| NCT01680250 | UNKNOWN | Polycystic Kidney Diseases |
Seoul National University Hospital |
2011-09 | PHASE2; PHASE3 |
| NCT00770263 | COMPLETED | Solid Tumors |
Washington University School of Medicine |
2009-05 | PHASE1 |
| NCT01526356 | COMPLETED | Angiofibromas; Tuberous Sclerosis |
The University of Texas Health Science Center, Houston |
2012-05 | PHASE2 |
| NCT01404104 | COMPLETED | Renal Cell Carcinoma |
St. Joseph's Healthcare Hamilton |
2008-09 | |
| NCT01016015 | COMPLETED | Metastatic Osteosarcoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Osteosarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma |
National Cancer Institute (NCI) |
2009-11 | PHASE2 |
| NCT01764607 | TERMINATED | Squamous Cell Skin Carcinoma |
University of Florida |
2013-04 | PHASE2 |
| NCT01417065 | COMPLETED | Advanced Cancer |
M.D. Anderson Cancer Center |
2010-08 | EARLY_PHASE1 |
| NCT00800722 | COMPLETED | Port Wine Stain |
University of California, Irvine |
2008-11 | PHASE1 |
| NCT00877773 | TERMINATED | Advanced Cancers |
M.D. Anderson Cancer Center |
2009-04 | PHASE1; PHASE2 |
| NCT00931255 | TERMINATED | Kidney Transplant; Delayed Graft Function |
University of Maryland, Baltimore |
2009-04 | PHASE4 |
| NCT02062892 | WITHDRAWN | Kidney Transplantation |
University of Colorado, Denver |
2013-12 | PHASE4 |
| NCT02013375 | TERMINATED | Sickle Cell Disease |
Damiano Rondelli, MD |
2014-04-10 | PHASE2 |
| NCT01788150 | COMPLETED | Coronary Artery Disease |
Svelte Medical Systems, Inc. |
2013-01 | |
| NCT01614795 | COMPLETED | Childhood Alveolar Soft Part Sarcoma; Childhood Angiosarcoma; Childhood Epithelioid Sarcoma; Childhood Fibrosarcoma; Childhood Gliosarcoma; Childhood Leiomyosarcoma; Childhood Liposarcoma; Childhood Malignant Peripheral Nerve Sheath Tumor; Childhood Synovial Sarcoma; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Soft Tissue Sarcoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Osteosarcoma; Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2012-06-18 | PHASE2 |
| NCT01827618 | COMPLETED | Invasive Bladder Cancer Stage II |
The University of Texas Health Science Center at San Antonio |
2012-04 | EARLY_PHASE1 |
| NCT01120028 | COMPLETED | Kidney Transplantation |
University of Oxford |
2010-09 | PHASE2; PHASE3 |
| NCT01548482 | COMPLETED | Adult Solid Neoplasm; Lung Carcinoid Tumor; Recurrent Digestive System Neuroendocrine Tumor G1; Recurrent Renal Cell Carcinoma; Recurrent Uterine Corpus Sarcoma; Stage III Renal Cell Cancer; Stage IIIB Uterine Sarcoma; Stage IIIC Uterine Sarcoma; Stage IV Renal Cell Cancer; Stage IVA Uterine Sarcoma; Stage IVB Uterine Sarcoma |
National Cancer Institute (NCI) |
2012-03 | PHASE1 |
| NCT01845311 | COMPLETED | Coronary Artery Disease; Coronary Artery Stenosis |
REVA Medical, Inc. |
2013-04 | |
| NCT01019434 | COMPLETED | Brain and Central Nervous System Tumors |
European Organisation for Research and Treatment of Cancer - EORTC |
2009-10 | PHASE2 |
| NCT01561404 | TERMINATED | Disorder Related to Renal Transplantation; Exercise, Aerobic; Muscle Strength |
Josep M Cruzado |
2011-09 | PHASE4 |
| NCT00698607 | COMPLETED | Coronary Artery Disease |
Seoul National University Hospital |
2008-06 | PHASE4 |
| NCT01592253 | UNKNOWN | Acute Rejection of Renal Transplant |
Seoul St. Mary's Hospital |
2012-05 | |
| NCT01256385 | COMPLETED | Recurrent Hypopharyngeal Squamous Cell Carcinoma; Recurrent Laryngeal Squamous Cell Carcinoma; Recurrent Laryngeal Verrucous Carcinoma; Recurrent Lip and Oral Cavity Squamous Cell Carcinoma; Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary; Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Recurrent Oral Cavity Verrucous Carcinoma; Recurrent Oropharyngeal Squamous Cell Carcinoma; Recurrent Salivary Gland Carcinoma; Salivary Gland Squamous Cell Carcinoma; Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary; Stage IV Hypopharyngeal Squamous Cell Carcinoma; Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Stage IVA Laryngeal Squamous Cell Carcinoma; Stage IVA Laryngeal Verrucous Carcinoma; Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma; Stage IVA Major Salivary Gland Carcinoma; Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Stage IVA Oral Cavity Verrucous Carcinoma; Stage IVA Oropharyngeal Squamous Cell Carcinoma; Stage IVB Laryngeal Squamous Cell Carcinoma; Stage IVB Laryngeal Verrucous Carcinoma; Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma; Stage IVB Major Salivary Gland Carcinoma; Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Stage IVB Oral Cavity Verrucous Carcinoma; Stage IVB Oropharyngeal Squamous Cell Carcinoma; Stage IVC Laryngeal Squamous Cell Carcinoma; Stage IVC Laryngeal Verrucous Carcinoma; Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma; Stage IVC Major Salivary Gland Carcinoma; Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Stage IVC Oral Cavity Verrucous Carcinoma; Stage IVC Oropharyngeal Squamous Cell Carcinoma; Tongue Carcinoma |
National Cancer Institute (NCI) |
2010-11 | PHASE2 |
| NCT01141244 | COMPLETED | Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2010-06 | PHASE1 |
| NCT01281917 | COMPLETED | Non-Hodgkins Lymphoma |
University of Wisconsin, Madison |
2011-02 | PHASE2 |
| NCT01363752 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2011-03-08 | PHASE4 |
| NCT00699491 | COMPLETED | Male Breast Carcinoma; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7 |
National Cancer Institute (NCI) |
2008-10-31 | PHASE1; PHASE2 |
| NCT00548717 | TERMINATED | Graft-vs-Host Disease |
Dana-Farber Cancer Institute |
2007-10 | PHASE2 |
| NCT01681381 | UNKNOWN | Ischemic Heart Disease; Myocardial Ischemia; Coronary Artery Lesions,Primary; Coronary Disease; Acute Coronary Syndrome; Furcation Lesion of Coronary Artery |
Essen Technology (Beijing) Co., Ltd. |
2012-09 | |
| NCT01909869 | COMPLETED | Ischemia; Coronary Artery Disease |
JW Medical Systems Ltd |
2013-01 | |
| NCT01065662 | COMPLETED | Endometrial Cancer; Ovarian Cancer; Cervical Cancer; Fallopian Tube Cancer; Peritoneal Cancer |
Susana M. Campos, MD |
2010-02 | PHASE1 |
| NCT00623012 | TERMINATED | Graft Versus Host Disease |
Yale University |
2008-02 | PHASE1; PHASE2 |
| NCT00397982 | COMPLETED | Recurrent Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma |
National Cancer Institute (NCI) |
2008-01 | PHASE2 |
| NCT00789308 | COMPLETED | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07-11 | PHASE2 |
| NCT01014234 | COMPLETED | Kidney Transplantation |
Fondazione IRCCS Policlinico San Matteo di Pavia |
2008-07 | PHASE2 |
| NCT00678769 | COMPLETED | Malignant Neoplasm |
National Cancer Institute (NCI) |
2008-05 | PHASE1 |
| NCT00973804 | TERMINATED | Leukemia; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; MDS; Multiple Myeloma |
National Cancer Institute (NCI) |
2009-08-25 | PHASE1 |
| NCT01684449 | COMPLETED | Advanced Soft Tissue Sarcoma |
Grupo Espanol de Investigacion en Sarcomas |
2010-01 | PHASE1; PHASE2 |
| NCT01445548 | COMPLETED | Age-Related Macular Degeneration; Geographic Atrophy |
National Eye Institute (NEI) |
2011-09 | PHASE1; PHASE2 |
| NCT00693446 | UNKNOWN | Pancreas Transplantation; Kidney Transplantation |
Nantes University Hospital |
2004-04 | PHASE4 |
| NCT00923273 | TERMINATED | Carcinoma, Non-Small-Cell Lung |
National Cancer Institute (NCI) |
2008-02-29 | PHASE1; PHASE2 |
| NCT00868829 | UNKNOWN | Coronary Heart Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2009-04 | |
| NCT01050985 | COMPLETED | Advanced Solid Tumors |
Georgetown University |
2010-07 | PHASE1 |
| NCT01282697 | COMPLETED | Refractory Solid Tumors in Children |
University Hospital, Strasbourg, France |
2011-04-22 | PHASE1 |
| NCT00513474 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Massachusetts General Hospital |
2008-01 | PHASE1 |
| NCT01383668 | WITHDRAWN | Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Mayo Clinic |
2011-06 | PHASE1 |
| NCT00919035 | COMPLETED | Prostate Cancer |
Oncology Specialists, S.C. |
2009-06 | PHASE2 |
| NCT01412164 | COMPLETED | Coronary Artery Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2011-08 | |
| NCT00921310 | TERMINATED | Carcinoma, Non-Small-Cell Lung |
Washington University School of Medicine |
2009-09 | PHASE1; PHASE2 |
| NCT01155258 | COMPLETED | Extensive Stage Small Cell Lung Cancer; Hereditary Paraganglioma; Male Breast Cancer; Malignant Paraganglioma; Metastatic Gastrointestinal Carcinoid Tumor; Metastatic Pheochromocytoma; Pancreatic Polypeptide Tumor; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Endometrial Carcinoma; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Recurrent Neuroendocrine Carcinoma of the Skin; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Pheochromocytoma; Recurrent Prostate Cancer; Recurrent Renal Cell Cancer; Recurrent Small Cell Lung Cancer; Recurrent Uterine Sarcoma; Regional Gastrointestinal Carcinoid Tumor; Regional Pheochromocytoma; Stage III Cervical Cancer; Stage III Endometrial Carcinoma; Stage III Neuroendocrine Carcinoma of the Skin; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage III Uterine Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Breast Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage IV Endometrial Carcinoma; Stage IV Neuroendocrine Carcinoma of the Skin; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Uterine Sarcoma; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Thyroid Gland Medullary Carcinoma |
University of Southern California |
2010-06 | PHASE1 |
| NCT00803010 | COMPLETED | Acute Graft Versus Host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2008-09 | PHASE2 |
| NCT01233167 | UNKNOWN | Coronary Artery Disease |
Sir Run Run Shaw Hospital |
2011-08 | |
| NCT00934791 | TERMINATED | Polycystic Liver Disease |
Mayo Clinic |
2009-02 | |
| NCT00555373 | COMPLETED | Renal Transplant |
Pediatric Nephrology of Alabama |
2007-11 | |
| NCT01061853 | TERMINATED | Oral Lichen Planus |
University Hospital, Tours |
2008-02 | PHASE3 |
| NCT01204450 | TERMINATED | Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific |
UNC Lineberger Comprehensive Cancer Center |
2009-11 | PHASE1 |
| NCT00971789 | COMPLETED | Cowden's Disease; Hamartoma Syndrome, Multiple |
National Cancer Institute (NCI) |
2008-07 | PHASE2 |
| NCT01396200 | COMPLETED | Myeloma |
Abramson Cancer Center at Penn Medicine |
2011-06 | EARLY_PHASE1 |
| NCT01009203 | TERMINATED | Squamous Cell Carcinoma |
New Mexico Cancer Research Alliance |
2009-12 | PHASE2 |
| NCT00861874 | COMPLETED | Acute Myeloid Leukemia |
University of Rochester |
2010-01 | PHASE1 |
| NCT02080624 | COMPLETED | Sturge- Weber Syndrome |
Clinica Universidad de Navarra, Universidad de Navarra |
2011-01 | PHASE2 |
| NCT01026792 | COMPLETED | Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma; Recurrent Cervical Carcinoma; Stage IIIA Cervical Cancer; Stage IIIB Cervical Cancer; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer |
National Cancer Institute (NCI) |
2009-12 | PHASE2 |
| NCT01405287 | COMPLETED | Coronary Artery Disease; Atherosclerosis; Acute Coronary Syndrome (ACS); Myocardial Infarction (MI) |
OrbusNeich |
2011-10 | PHASE2 |
| NCT00076570 | COMPLETED | Kidney Transplantation |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2004-01 | PHASE2 |
| NCT00887640 | TERMINATED | Prostate Cancer |
Duke University |
2009-07 | PHASE2 |
| NCT00908466 | COMPLETED | Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis |
Johns Hopkins University |
2009-07 | PHASE1 |
| NCT01255956 | UNKNOWN | In-Stent Restenosis |
Medical University of Warsaw |
2010-12 | PHASE3 |
| NCT01281943 | WITHDRAWN | Liver Neoplasms |
Washington University School of Medicine |
2011-06 | PHASE2 |
| NCT00775593 | COMPLETED | Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2008-12 | PHASE2 |
| NCT01294748 | COMPLETED | Coronary Artery Disease |
Micell Technologies |
2011-02 | PHASE2 |
| NCT00909831 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Abramson Cancer Center at Penn Medicine |
2008-10 | PHASE1 |
| NCT01196819 | COMPLETED | Coronary Artery Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2010-09 | |
| NCT00667485 | COMPLETED | Advanced Cancer; Metastatic Cancer |
University of Chicago |
2008-04 | PHASE1 |
| NCT01182883 | WITHDRAWN | Brain Stem Neoplasms; Glioma; Pinealoma |
National Cancer Institute (NCI) |
2010-07-28 | PHASE1 |
| NCT00997711 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2009-04 | PHASE4 |
| NCT01170052 | WITHDRAWN | Mantle Cell Lymphoma |
Charite University, Berlin, Germany |
2010-05 | PHASE1; PHASE2 |
| NCT01632605 | COMPLETED | ADPKD |
Medical University of Vienna |
2009-11 | |
| NCT00631371 | COMPLETED | Renal Cell Carcinoma |
Pfizer |
2008-04 | PHASE3 |
| NCT00787969 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2009-04 | PHASE1 |
| NCT00286156 | COMPLETED | Polycystic Kidney Diseases |
The Cleveland Clinic |
2006-10 | PHASE1; PHASE2 |
| NCT00353301 | COMPLETED | Renal Cell Carcinoma |
University of Colorado, Denver |
2006-07 | PHASE2 |
| NCT00589563 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Secondary Myelofibrosis; Small Intestine Cancer |
City of Hope Medical Center |
2007-05 | PHASE2 |
| NCT01851408 | WITHDRAWN | Melanoma; Recurrent Melanoma; Stage III Melanoma; Stage IV Melanoma |
National Cancer Institute (NCI) |
2006-04 | PHASE2 |
| NCT01072890 | COMPLETED | Solid Tumors |
University of California, Davis |
2010-02 | PHASE1 |
| NCT00509431 | COMPLETED | Brain and Central Nervous System Tumors |
Jonsson Comprehensive Cancer Center |
2006-08 | PHASE1 |
| NCT01083368 | COMPLETED | Prostate Cancer |
Case Comprehensive Cancer Center |
2009-01 | PHASE1; PHASE2 |
| NCT00896012 | COMPLETED | Kidney Transplantation |
University at Buffalo |
2008-01 | PHASE4 |
| NCT01202058 | TERMINATED | Atherosclerotic Coronary Artery Disease |
Cordis US Corp. |
2010-08 | PHASE3 |
| NCT01418794 | UNKNOWN | Acute Coronary Syndromes |
Shenyang Northern Hospital |
2010-10 | PHASE4 |
| NCT01034345 | UNKNOWN | Liver Transplantation |
Hospital Clinic of Barcelona |
2009-11 | PHASE2 |
| NCT00464555 | COMPLETED | Type 1 Diabetes Mellitus |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-12 | PHASE2 |
| NCT01375296 | UNKNOWN | Coronary Artery Disease |
Shanghai Jiao Tong University School of Medicine |
2009-05 | PHASE2; PHASE3 |
| NCT01492894 | WITHDRAWN | Kidney Graft Dysfunction |
University of Minnesota |
2008-01 | PHASE4 |
| NCT00525889 | COMPLETED | Diabetes Mellitus, Type 1 |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-08 | PHASE1 |
| NCT00604357 | COMPLETED | End Stage Liver Disease; Impaired Renal Function |
University of Regensburg |
2008-12 | PHASE3 |
| NCT01620307 | COMPLETED | H1N1 Pneumonia; Hypoxemia |
Chang Gung Memorial Hospital |
2009-06 | PHASE2 |
| NCT00793221 | COMPLETED | Coronary Artery Disease; Coronary Occlusion; Percutaneous Coronary Intervention |
Raul Moreno |
2008-11 | PHASE3 |
| NCT00635284 | COMPLETED | Solid Tumors |
Celgene |
2007-12-01 | PHASE1 |
| NCT00703170 | COMPLETED | Resistant Solid Malignancies |
Washington University School of Medicine |
2008-03 | PHASE1 |
| NCT01217125 | COMPLETED | Angiomyolipoma |
Fundacio Puigvert |
2008-10 | PHASE4 |
| NCT00105001 | COMPLETED | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndrome; Refractory Chronic Lymphocytic Leukemia; Refractory Plasma Cell Myeloma; Waldenstrom Macroglobulinemia; Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Lymphoma; Childhood Myelodysplastic Syndrome; Stage II Contiguous Adult Burkitt Lymphoma; Stage II Contiguous Adult Diffuse Large Cell Lymphoma; Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma; Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma; Stage II Adult Contiguous Immunoblastic Lymphoma; Stage II Contiguous Adult Lymphoblastic Lymphoma; Stage II Grade 1 Contiguous Follicular Lymphoma; Stage II Grade 2 Contiguous Follicular Lymphoma; Stage II Grade 3 Contiguous Follicular Lymphoma; Stage II Contiguous Mantle Cell Lymphoma; Stage II Non-Contiguous Adult Burkitt Lymphoma; Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma; Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma; Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma; Stage II Adult Non-Contiguous Immunoblastic Lymphoma; Stage II Non-Contiguous Adult Lymphoblastic Lymphoma; Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Stage II Non-Contiguous Mantle Cell Lymphoma; Stage II Small Lymphocytic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Burkitt Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Secondary Myelodysplastic Syndrome; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Immunoblastic Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Burkitt Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Burkitt Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Burkitt Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Burkitt Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma |
Fred Hutchinson Cancer Center |
2004-11 | PHASE2 |
| NCT00467194 | COMPLETED | Liver Cancer |
National Cancer Centre, Singapore |
2006-12 | PHASE1 |
| NCT01797315 | TERMINATED | Renal Transplant Patients at High-risk for Skin Cancer |
University Hospital of Berlin |
2007-03 | PHASE4 |
| NCT00317798 | COMPLETED | Drug/Agent Toxicity by Tissue/Organ; Multiple Myeloma and Plasma Cell Neoplasm |
University of Rochester |
2006-04 | PHASE1 |
| NCT01236378 | COMPLETED | Transplant Rejection; Renal Transplantation |
Pfizer |
2010-12 | PHASE1 |
| NCT00485004 | COMPLETED | In Stent Restenosis |
Seung-Jung Park |
2007-03 | PHASE4 |
| NCT00133887 | COMPLETED | Skin Cancer; Kidney Transplantation |
Hospices Civils de Lyon |
2004-04 | PHASE3 |
| NCT01184885 | COMPLETED | Lymphoid Malignancies (New or Relapsed); Acute Lymphoblastic Leukemia; Burkitt Lymphoma; Lymphoblastic Lymphoma; Mantle Cell Lymphoma; Adult T-cell Leukemia/Lymphoma |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2010-07 | EARLY_PHASE1 |
| NCT00876434 | COMPLETED | Anterior Uveitis |
National Eye Institute (NEI) |
2009-04-01 | PHASE1 |
| NCT00928798 | COMPLETED | Birt-Hogg-Dubé Syndrome |
Maastricht University Medical Center |
2010-01 | PHASE3 |
| NCT01031901 | COMPLETED | Tuberous Sclerosis; Neurofibromatoses; Angiofibroma; Neurofibroma |
The University of Texas Health Science Center, Houston |
2009-12 | PHASE1 |
| NCT00922129 | WITHDRAWN | Prostate Cancer |
St. Joseph's Healthcare Hamilton |
2009-09 | PHASE2; PHASE3 |
| NCT00827684 | COMPLETED | Metastatic Colorectal Cancer |
Vejle Hospital |
2009-03 | PHASE2 |
| NCT00483262 | COMPLETED | Multiple Myeloma |
Dana-Farber Cancer Institute |
2007-05 | PHASE1; PHASE2 |
| NCT00281957 | COMPLETED | Recurrent Melanoma; Stage IV Melanoma |
National Cancer Institute (NCI) |
2007-08 | PHASE2 |
| NCT01079767 | TERMINATED | Liver Cancer |
Federation Francophone de Cancerologie Digestive |
2010-01 | PHASE2 |
| NCT00428454 | COMPLETED | Coronary Artery Disease; Coronary Disease; Coronary Stenosis |
R&D Cardiologie |
2007-01 | PHASE3 |
| NCT00376870 | UNKNOWN | Coronary Atherosclerosis; Coronary Restenosis; Diabetes |
University of Rome Tor Vergata |
2008-07 | PHASE3 |
| NCT00311311 | TERMINATED | Atherosclerosis; Kidney Failure |
Pfizer |
2006-04 | PHASE3 |
| NCT01023919 | TERMINATED | Coronary Artery Disease; Diabetes Mellitus |
Harbin Medical University |
2009-11 | |
| NCT00672204 | TERMINATED | Type 1 Diabetes Mellitus; Hypoglycemia |
University of Minnesota |
2007-11 | PHASE1; PHASE2 |
| NCT00316849 | COMPLETED | Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma |
National Cancer Institute (NCI) |
2006-05 | PHASE1 |
| NCT00506948 | TERMINATED | Hematological Malignancies; Myelodysplastic Syndrome; Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2006-09 | PHASE2 |
| NCT01507519 | COMPLETED | Coronary Artery Disease |
Meril Life Sciences Pvt. Ltd. |
2009-04 | |
| NCT00414648 | COMPLETED | Lymphangioleiomyomatosis |
University of Cincinnati |
2006-12 | PHASE3 |
| NCT00598533 | COMPLETED | Coronary Heart Disease |
Deutsches Herzzentrum Muenchen |
2008-02 | PHASE4 |
| NCT01220297 | TERMINATED | Hematologic Diseases; Acute-graft-versus-host Disease; Leukemia; Non-Hodgkin Lymphoma (NHL); Hodgkin Lymphoma |
Stanford University |
2006-08 | PHASE2 |
| NCT00920309 | TERMINATED | Autosomal Dominant Polycystic Kidney Disease |
Yale University |
2009-06 | PHASE2; PHASE3 |
| NCT00901849 | COMPLETED | Low-grade Gliomas |
Roger Packer |
2007-05 | PHASE1 |
| NCT00337376 | TERMINATED | Advanced Solid Cancers |
Yale University |
2006-02 | PHASE1 |
| NCT01449955 | COMPLETED | Posttraumatic Stress Disorder |
University of Texas Southwestern Medical Center |
2008-08 | |
| NCT01183247 | COMPLETED | Comparative Study; Immunosuppressive Agents |
University Hospital, Basel, Switzerland |
2008-07 | PHASE4 |
| NCT00390195 | UNKNOWN | Hepatocellular Carcinoma |
National Health Research Institutes, Taiwan |
2006-10 | PHASE1; PHASE2 |
| NCT00411788 | COMPLETED | Breast Cancer |
Yale University |
2006-12 | PHASE2 |
| NCT00276744 | TERMINATED | Pancreatic Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-10 | PHASE2 |
| NCT00112736 | COMPLETED | Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Pilocytic Astrocytoma; Adult Pineal Gland Astrocytoma; Adult Subependymal Giant Cell Astrocytoma; Recurrent Adult Brain Tumor |
National Cancer Institute (NCI) |
2005-04 | PHASE1; PHASE2 |
| NCT00825773 | UNKNOWN | Ischemia; Cardiac Death; Myocardial Infarction |
JW Medical Systems Ltd |
2008-10 | PHASE4 |
| NCT00126672 | COMPLETED | Nonmalignant Neoplasm; Tuberous Sclerosis; Lymphangioleimyomatosis; Kidney Angiomyolipoma |
Dana-Farber Cancer Institute |
2005-12-20 | PHASE2 |
| NCT00795886 | COMPLETED | Acute Lymphoblastic Leukemia |
University of Utah |
2005-08 | PHASE2 |
| NCT00715884 | UNKNOWN | Coronary Artery Disease; Coronary Atherosclerosis |
Cordis US Corp. |
2008-07 | |
| NCT00590174 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2007-10 | PHASE4 |
| NCT00555256 | COMPLETED | Non-Small Cell Lung Cancer |
Washington University School of Medicine |
2007-11 | PHASE1 |
| NCT00346151 | TERMINATED | Renal Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-12 | PHASE2 |
| NCT00659568 | COMPLETED | Breast Cancer; Endometrial Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific |
London Health Sciences Centre |
2008-03 | PHASE1 |
| NCT02296762 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2010-02 | PHASE1 |
| NCT00335764 | COMPLETED | Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Tumor |
National Cancer Institute (NCI) |
2006-04 | PHASE1; PHASE2 |
| NCT00304954 | COMPLETED | Age-Related Macular Degeneration; Choroidal Neovascularization |
National Eye Institute (NEI) |
2006-02 | PHASE2 |
| NCT01090466 | COMPLETED | Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer |
Cardiff University |
2008-02 | PHASE1; PHASE2 |
| NCT02688829 | COMPLETED | Coronary Heart Disease |
Shanghai MicroPort Medical (Group) Co., Ltd. |
2009-12 | |
| NCT00331409 | COMPLETED | Kidney Cancer |
OHSU Knight Cancer Institute |
2006-01 | PHASE2 |
| NCT00346918 | COMPLETED | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
University of Zurich |
2006-06 | PHASE3 |
| NCT01709136 | TERMINATED | Hypertension |
University of Pittsburgh |
2005-12 | PHASE2; PHASE3 |
| NCT00780104 | COMPLETED | Myeloid Leukemias; AML; Leukemia; CML |
Abramson Cancer Center at Penn Medicine |
2007-07 | PHASE1 |
| NCT00422968 | COMPLETED | Coronary Artery Disease |
Seung-Jung Park |
2005-03 | PHASE3 |
| NCT00714883 | TERMINATED | Coronary Disease |
Cordis US Corp. |
2008-06 | PHASE2 |
| NCT00874562 | COMPLETED | Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute |
2007-07 | PHASE1 |
| NCT00121810 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2003-08 | PHASE4 |
| NCT00712491 | TERMINATED | Age-related Macular Degeneration; Choroidal Neovascularization |
Santen Inc. |
2008-09 | PHASE1; PHASE2 |
| NCT01242306 | COMPLETED | Endothelial Dysfunction |
Azienda Ospedaliera San Camillo Forlanini |
2009-03 | PHASE1; PHASE2 |
| NCT00814944 | COMPLETED | Dry Eye |
Santen Inc. |
2009-04 | PHASE2 |
| NCT00223678 | COMPLETED | Kidney Transplant |
Vanderbilt University Medical Center |
2000-06 | PHASE4 |
| NCT00396721 | COMPLETED | Glomerulonephritis, IGA; Nephropathy, IGA; IGA Nephropathy |
Josep m Cruzado |
2006-01 | PHASE2 |
| NCT00593008 | TERMINATED | Pancreatic Adenocarcinoma |
Massachusetts General Hospital |
2007-10 | PHASE1 |
| NCT00790439 | WITHDRAWN | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07 | PHASE2 |
| NCT00523432 | COMPLETED | Genital Neoplasms, Female |
University of Chicago |
2007-08 | PHASE1 |
| NCT00450320 | COMPLETED | Sarcoma |
AIDS Malignancy Consortium |
2007-10 | PHASE1 |
| NCT00109967 | COMPLETED | Recurrent Mantle Cell Lymphoma |
National Cancer Institute (NCI) |
2005-05 | PHASE2 |
| NCT00490789 | UNKNOWN | Tuberous Sclerosis; Lymphangioleiomyomatosis |
Cardiff University |
2005-10 | PHASE2 |
| NCT01133925 | UNKNOWN | Coronary Artery Disease |
A.O. Ospedale Papa Giovanni XXIII |
2008-05 | PHASE4 |
| NCT00491517 | COMPLETED | Polycystic Kidney |
Mario Negri Institute for Pharmacological Research |
2007-03 | PHASE2 |
| NCT00808899 | TERMINATED | Neuroblastoma |
St. Jude Children's Research Hospital |
2008-12 | PHASE2 |
| NCT00449280 | COMPLETED | Advanced Solid Tumor |
University of Chicago |
2006-11 | PHASE1 |
| NCT00368914 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-12 | PHASE1 |
| NCT00072176 | COMPLETED | Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma; Stage IIIA Endometrial Carcinoma; Stage IIIB Endometrial Carcinoma; Stage IIIC Endometrial Carcinoma; Stage IVA Endometrial Carcinoma; Stage IVB Endometrial Carcinoma |
National Cancer Institute (NCI) |
2004-05 | PHASE2 |
| NCT00375245 | COMPLETED | Tumors; Neoplasm Metastasis |
University of Chicago |
2006-09 | PHASE1 |
| NCT00068302 | TERMINATED | Leukemia; Lymphoma |
Children's Hospital of Philadelphia |
2003-01 | PHASE1 |
| NCT00355862 | COMPLETED | Hepatocellular Carcinoma |
University of Regensburg |
2006-01 | PHASE3 |
| NCT00598676 | COMPLETED | Coronary Heart Disease |
Deutsches Herzzentrum Muenchen |
2007-09 | PHASE4 |
| NCT00282282 | COMPLETED | Graft Versus Host Disease; GVHD |
Dana-Farber Cancer Institute |
2006-01 | PHASE2 |
| NCT00776373 | TERMINATED | ALL; Burkitt's Lymphoma; Lymphoblastic Leukemia; CML |
Abramson Cancer Center at Penn Medicine |
2007-01 | PHASE1; PHASE2 |
| NCT00708591 | COMPLETED | Advanced Cancer |
University of Chicago |
2004-10 | PHASE1 |
| NCT00478608 | COMPLETED | Renal Transplant |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-03 | PHASE3 |
| NCT00697372 | COMPLETED | Coronary Artery Disease; Coronary Stenosis |
Catholic University of the Sacred Heart |
2007-09 | PHASE4 |
| NCT00627900 | COMPLETED | Coronary Artery Disease |
Charite University, Berlin, Germany |
2003-04 | PHASE4 |
| NCT00422565 | TERMINATED | Myocardial Infarction |
Seung-Jung Park |
2006-10 | PHASE4 |
| NCT00707135 | COMPLETED | Advanced Cancer |
University of Chicago |
2005-06 | PHASE1 |
| NCT00170053 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2005-06 | PHASE1 |
| NCT00499486 | COMPLETED | Pancreatic Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-01 | PHASE2 |
| NCT00452361 | TERMINATED | Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-04 | PHASE4 |
| NCT00130546 | COMPLETED | Coronary Artery Disease |
University Hospital Freiburg |
2004-11 | PHASE3 |
| NCT00195273 | COMPLETED | Graft vs Host Disease; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-11 | PHASE3 |
| NCT00402415 | TERMINATED | Tumors |
Yale University |
2006-02 | PHASE1 |
| NCT00118742 | COMPLETED | Liver Transplantation |
Hoffmann-La Roche |
2005-08 | PHASE4 |
| NCT00376688 | COMPLETED | Recurrent Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7 |
National Cancer Institute (NCI) |
2006-07-11 | PHASE2 |
| NCT00133237 | COMPLETED | Coronary Disease |
Deutsches Herzzentrum Muenchen |
2005-07 | PHASE4 |
| NCT00306397 | COMPLETED | Kidney Transplantation |
University Hospital, Basel, Switzerland |
2005-01 | PHASE4 |
| NCT00401115 | COMPLETED | Diabetic Macular Edema; Diabetic Retinopathy |
Santen Inc. |
2006-09 | PHASE1 |
| NCT00038948 | COMPLETED | Renal Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2002-01 | PHASE3 |
| NCT00752362 | COMPLETED | Coronary Restenosis |
Sahajanand Medical Technologies Limited |
2006-03 | PHASE4 |
| NCT00583063 | COMPLETED | Solid Tumors |
University of Chicago |
2007-10 | EARLY_PHASE1 |
| NCT00275093 | COMPLETED | Hepatic Complications; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2005-12 | PHASE1 |
| NCT00433485 | COMPLETED | Neoplastic Syndrome; Non-melanomatous Skin Cancer |
Yale University |
PHASE1 | |
| NCT00311623 | COMPLETED | Prostate Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2006-08 | PHASE1; PHASE2 |
| NCT00204321 | COMPLETED | Renal Transplantation |
University Hospital Muenster |
2005-06 | PHASE4 |
| NCT00512668 | TERMINATED | Adenocarcinoma of the Prostate; Recurrent Prostate Cancer |
National Cancer Institute (NCI) |
2007-09 | PHASE1 |
| NCT02554955 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
2004-02 | PHASE4 |
| NCT00275535 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2001-04 | PHASE4 |
| NCT00552669 | COMPLETED | Coronary Heart Disease; Coronary Restenosis |
Centro de estudios en Cardiologia Intervencionista |
2006-01 | PHASE4 |
| NCT00350454 | COMPLETED | Coronary Heart Disease |
Deutsches Herzzentrum Muenchen |
2006-06 | PHASE4 |
| NCT00050713 | COMPLETED | Membranous Glomerulonephritis; Lupus Membranous Nepropathy |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2002-12-17 | PHASE2 |
| NCT00117598 | COMPLETED | Lymphoma |
Pfizer |
2005-05 | PHASE3 |
| NCT00350181 | COMPLETED | Leukemia; Lymphoma, Non-Hodgkin; Hematologic Diseases; Acute GVHD |
Stanford University |
2006-08 | PHASE2 |
| NCT00255658 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2005-09 | PHASE1 |
| NCT00229515 | UNKNOWN | Myocardial Infarction |
Marco Valgimigli |
2004-11 | PHASE4 |
| NCT00028028 | COMPLETED | Extensive Stage Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2002-02 | PHASE2 |
| NCT00296361 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-10 | PHASE3 |
| NCT00241189 | COMPLETED | Systemic Sclerosis |
University of California, Los Angeles |
2002-08 | PHASE1; PHASE2 |
| NCT00022724 | COMPLETED | Brain and Central Nervous System Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2001-08-27 | PHASE1; PHASE2 |
| NCT00071968 | COMPLETED | Prostate Cancer |
Jonsson Comprehensive Cancer Center |
2003-08 | PHASE2 |
| NCT00170820 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2005-02 | PHASE4 |
| NCT00497172 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2004-01 | PHASE4 |
| NCT00061360 | COMPLETED | Severe Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2003-06-26 | PHASE2 |
| NCT00033267 | COMPLETED | Recurrent Mantle Cell Lymphoma |
National Cancer Institute (NCI) |
2002-04 | PHASE2 |
| NCT00087074 | COMPLETED | Gastrointestinal Stromal Tumor; Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma |
National Cancer Institute (NCI) |
2004-06 | PHASE2 |
| NCT01060605 | COMPLETED | Diabetes Mellitus, Type 1 |
IRCCS San Raffaele |
2001-10 | PHASE3 |
| NCT00759850 | COMPLETED | Acute Myocardial Infarction |
San Giuseppe Moscati Hospital |
2003-10 | PHASE2; PHASE3 |
| NCT00812123 | COMPLETED | Kidney Transplantation; Chronic Kidney Disease |
University Hospital, Basel, Switzerland |
2001-01 | PHASE4 |
| NCT00047073 | COMPLETED | Brain and Central Nervous System Tumors |
Jonsson Comprehensive Cancer Center |
2002-07 | PHASE1; PHASE2 |
| NCT00217256 | COMPLETED | Coronary Artery Disease |
Medtronic Vascular |
2004-02 | |
| NCT00495898 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2002-11 | PHASE4 |
| NCT00062751 | COMPLETED | Breast Neoplasms |
Wyeth is now a wholly owned subsidiary of Pfizer |
2002-12 | PHASE2 |
| NCT00089037 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2003-06 | PHASE1; PHASE2 |
| NCT00075647 | COMPLETED | Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage II Pancreatic Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer |
National Cancer Institute (NCI) |
2003-12 | PHASE2 |
| NCT00232739 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2003-09 | PHASE3 |
| NCT00023231 | COMPLETED | End-Stage Renal Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2001-02 | |
| NCT00232791 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2004-01 | PHASE2; PHASE3 |
| NCT00859183 | COMPLETED | Coronary Restenosis |
Deutsches Herzzentrum Muenchen |
2001-10 | PHASE4 |
| NCT00285194 | COMPLETED | Type 1 Diabetes; Hypoglycemia |
University of Minnesota |
2000-04 | PHASE1; PHASE2 |
| NCT00232856 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2002-12 | PHASE4 |
| NCT00235157 | COMPLETED | Renal Artery Stenosis |
Cordis US Corp. |
2001-11 | PHASE2 |
| NCT00235144 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2001-03 | PHASE3 |
| NCT00003712 | COMPLETED | Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
The University of Texas Health Science Center at San Antonio |
2001-01 | PHASE1 |
| NCT00186667 | COMPLETED | Graft vs Host Disease; Blood and Marrow Transplant (BMT) |
Stanford University |
1999-01 | PHASE2 |
| NCT00489164 | TERMINATED | Peripheral Vascular Diseases |
Cordis US Corp. |
2002-08 | PHASE1; PHASE2 |
| NCT00140530 | COMPLETED | Coronary Disease |
Deutsches Herzzentrum Muenchen |
2004-03 | PHASE4 |
| NCT00123331 | COMPLETED | Heart Transplantation; Renal Failure |
Heidelberg University |
2003-10 | PHASE4 |
| NCT00402636 | COMPLETED | Coronary Heart Disease |
Deutsches Herzzentrum Muenchen |
2005-03 | PHASE4 |
| NCT00332397 | COMPLETED | Coronary Disease |
Deutsches Herzzentrum Muenchen |
2006-03 | PHASE4 |
| NCT00297661 | COMPLETED | Coronary Heart Disease |
University of Bern |
2003-04 | PHASE4 |
| NCT00305396 | COMPLETED | Kidney Transplantation |
Vanderbilt University |
2004-04 | PHASE4 |
| NCT00290069 | UNKNOWN | Kidney Diseases; Graft Rejection |
Sociedad Andaluza de Trasplantes de Organos y Tejidos |
PHASE4 | |
| NCT00309270 | COMPLETED | Kidney Transplant |
Mario Negri Institute for Pharmacological Research |
2003-02 | PHASE2 |
| NCT00152308 | TERMINATED | Coronary Disease |
Translumina GmbH |
2004-12 | PHASE4 |
| NCT00233779 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2003-10 | PHASE2 |
| NCT00452517 | COMPLETED | Acute Coronary Syndrome |
University of Zagreb |
2004-03 | PHASE4 |
| NCT00078689 | COMPLETED | Uveitis |
National Eye Institute (NEI) |
2004-03-03 | PHASE1 |
| NCT00233818 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2000-02 | PHASE1; PHASE2 |
| NCT00098462 | WITHDRAWN | Lung Cancer |
Jonsson Comprehensive Cancer Center |
2004-10 | PHASE1; PHASE2 |
| NCT00151658 | COMPLETED | Ischaemic Heart Disease |
Rigshospitalet, Denmark |
2002-10 | |
| NCT00482183 | COMPLETED | Coronary Artery Disease; Type 2 Diabetes Mellitus |
Showa University |
2003-07 | PHASE2; PHASE3 |
| NCT00195429 | COMPLETED | Kidney Failure; Graft vs Host Disease |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-08 | PHASE4 |
| NCT00188955 | COMPLETED | Kidney Transplantation |
University of Manitoba |
2004-03 | PHASE4 |
| NCT00457808 | COMPLETED | Tuberous Sclerosis; Lymphangioleiomyomatosis |
Children's Hospital Medical Center, Cincinnati |
2002-12 | PHASE2 |
| NCT00141804 | UNKNOWN | Kidney Transplantation |
University Hospital Muenster |
2002-01 | PHASE3 |
| NCT00428064 | COMPLETED | Renal Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
1998-05 | PHASE3 |
| NCT00788580 | WITHDRAWN | Unspecified Adult Solid Tumor, Protocol Specific |
SWOG Cancer Research Network |
PHASE1 | |
| NCT00233792 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
1999-12 | PHASE1; PHASE2 |
| NCT00012142 | COMPLETED | Prostate Cancer |
Jonsson Comprehensive Cancer Center |
2000-09 | PHASE2 |
| NCT00245401 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2003-08 | PHASE4 |
| NCT00223028 | COMPLETED | Renal Transplantation |
University Hospital Schleswig-Holstein |
2005-04 | PHASE4 |
| NCT00518271 | COMPLETED | Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2000-04 | PHASE2 |
| NCT00166842 | UNKNOWN | Transplantation; Kidney Transplantation; Immunosuppression |
National Taiwan University Hospital |
2002-09 | PHASE4 |
| NCT00493194 | UNKNOWN | Kidney Failure, Chronic; Transplantation; Immunosuppression; Interstitial Fibrosis |
University Hospital, Antwerp |
2005-05 | PHASE4 |
| NCT00231283 | COMPLETED | Coronary Artery Disease |
Cordis US Corp. |
2004-04 | PHASE3 |
| NCT00417677 | TERMINATED | Renal Cell Carcinoma |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-03 | PHASE1; PHASE2 |
| NCT00140543 | COMPLETED | Diabetes Mellitus, Type 1; Diabetic Nephropathy |
EUROSPK Study Group |
2002-02 | PHASE3 |
| NCT00002790 | WITHDRAWN | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
1996-03 | PHASE1; PHASE2 |
| NCT00261820 | COMPLETED | Graft Rejection; Kidney Failure; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
PHASE4 | |
| NCT00288535 | UNKNOWN | Coronary Artery Disease |
University Heart Center Freiburg - Bad Krozingen |
2005-03 | PHASE4 |
| NCT00282217 | COMPLETED | Kidney Failure; Kidney Diseases |
Wyeth is now a wholly owned subsidiary of Pfizer |
2006-08 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-09-04)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Rapamycin (Sirolimus) Mechanism of Action: mTOR Inhibition in Senescent Cells Research
- Rapamycin (Sirolimus): Selectivity & Specificity
- Rapamycin (Sirolimus) Working Concentration | Cell Culture | Treatment
- Rapamycin (Sirolimus) Solubility in DMSO
- Rapamycin (Sirolimus) Stock Solution
- Rapamycin (Sirolimus) Storage
- Rapamycin (Sirolimus) Stability
- Rapamycin (Sirolimus) Combination Database
- Rapamycin (Sirolimus) Molecular Weight
- Rapamycin (Sirolimus) SMILES
- Rapamycin (Sirolimus) CAS Number
- Rapamycin (Sirolimus) Chemical Structure (2D and 3D)
- Rapamycin (Sirolimus) IC50 for Cell-based and Cell-free Assays
- Rapamycin (Sirolimus) Sigma (553210)? Try a better option.
- Rapamycin (Sirolimus) MedChemExpress (HY-10219)? Try a better option.
- Rapamycin (Sirolimus) Tocris (1292)? Try a better option.
- Rapamycin (Sirolimus) Cayman (13346)? Try a better option.
- Rapamycin (Sirolimus) Cell Signaling Technology (73364)? Try a better option.
- Rapamycin (Sirolimus) SDS|MSDS